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The concentration of 5-HT in the rat brain displays a 
marked 2 4-hour variation which is 180° out of phase with 
that observed for total brain TRY levels. This investigation 
was undertaken to study the factors which might prove 
responsible for this difference. Previous experiments 
showed 5-HIAA levels were purely a reflection of 5-HT 
concentrations i.e. the latter were not low in the dark 
phase because turnover was high.
TRY in the plasma has the unusual property of binding to 
albumin and it is the 'free' fraction which is functionally 
important. A comparison was made of 'free' and total TRY 
levels in the brain as TRY hydroxylase is unsaturated with 
substrate and fluctuations in the functional TRY pool may 
be important in controlling 5-HT levels. A 24-hour variation 
in 'free' TRY was found^again there was a 180° phase 
difference with the 5-HT rhythm.
The activity of the two synthetic enzymes TRY hydroxylase 
and 5-HTP decarboxylase were measured by in vitro methods 
(radiometric and fluorimetric, respectively). No 
significant 2 4-hour variation in enzyme activity was 
evident, suggesting no regulation by synthesis rate.
(iv)
In vivo studies followed in which a behavioural model of 
induced hyperactivity, thought to reflect central 
serotonergic activity, showed a 24-hour variation in 
hyperactivity, the peak level occurring in the latter part 
of the light period. The effect of re-uptake blockade on 
this syndrome indicated a reduced rate of re-uptake 
coinciding with increased hyperactivity rather than an 
increased rate of 5-HT release.
In the light of these results, the possibility is considered 
that regulation of 5-HT levels is not via synthesis but 
that 5-HT is produced in excess and that functional control 
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5-Hydroxytryptamine (5-HT) is widely distributed in the central 
nervous system (CNS) of mammals, and there is evidence that 
it functions there as a neurotransmitter. It has been 
postulated that serotonergic neurons are involved in numerous 
functions in the brain, including regulation of various types 
of behaviour, body temperature, food intake, neuroendocrine 
function, sleep, and sexual activity.
The concentration of 5-hydroxytryptamine in the rat brain 
displays a marked circadian variation and it is hoped that 
the results presented in this thesis will elucidate the 
biochemical factors which control this persistent rhythm.
It is also hoped that through this work a more general picture 
of the way in which the functional activity of serotonergic 
neurons are controlled in the brain may emerge.
It is the purpose of this chapter to introduce the reader to 
the characteristics of circadian rhythms which are particularly 
relevant to this work and to give a resume of previous 
investigations involved in the discovery, isolation, 
distribution and metabolism of this amine and to shed light 
on its role in the CNS.
1.1 Circadian Rhythms
Life on earth is and always has been exposed to strong and 
rhythmic environmental changes caused by planetary movements 
Thus the rotation of the earth on its polar axis gives rise
to the dominant cycle of day and night; the revolution of
the earth around the sun gives rise to the procession of the 
seasons; and the more complicated movements of the moon in
relation to the earth and the sun give rise to the lunar
month and to the tidal cycles.
During their long evolutionary history, organisms have 
developed various endogenous rhythms whose periods match 
those of the environmental changes outlined above, eg. 
cycles of day and night (circadian, period 24 hours), lunar 
(circalunar, period 29 days), tide (circatidal, period
12.4 or 24.8 hours), the seasons (circannual, period a 
year), or the time between successive spring and low waters 
(semilunar or cirasyzygic, period 14.7 days). The best 
known of these rhythmic phenomena is the circadian (from 
cira, about; dies, a day).
The cycle of day and night is important for a number of 
reasons. Practically all the energy entering the biotic 
environment is derived from the sun, being incorporated by 
green plants during the day but not at night. Correlated 
with this rhythm in light intensity are the rhythms of 
temperature and humidity; in other words, the three most 
important environmental variables have a strong 24-hour 
variation.
Circadian rhythms, however, are those that persist when all 
environmental fluctuations are excluded,and in this free- 
running condition show a natural period which is
1) close to but rarely equal to that of solar day
2) very accurate
3) temperature - compensated.
These circadian rhythms may be observed at all levels of 
organisation except, apparently, in the prokaryotes. 
Unicellular organisms, particularly algae, show circadian 
rhythms of phototaxis cell division, photosynthesis and 
bioluminescence (Sweeney, 1969). Fungi, such as Neurospora 
spp. and Pilobolus spp. show a 2 4-hour rhythm of sporulation, 
although other fungi may show a variety of rhythms with a 
non-circadian pattern (Jerebzoff, 1965). 'Higher' plants 
and animals show a vast array of rhythms, some of the most 
frequently studied being leaf movements of plants, and the 
sleep-wake or activity cycles of insects, birds and mammals.
In whole populations, certain 'one-in-a-lifetime' events, 
such as egg hatch, moulting, pupation, and adult emergence 
of insects, show a pronounced circadian rhythm in a mixed-age 
population. One of the most intensively investigated of such 
systems is the rhythm of pupal ecolsion in the fruit fly 
Drosophila pseudoobscura (Pittendrigh, 1954, 1960, 1966).
Even cultured cells, tissues and organs may show persistant 
circadian rhythms when isolated from the whole organism. Thus 
in plants, isolated sections of leaves continue to show 
diurnal fluctuations in turgor pressure, growth and CO2 output 
(Wilkins, 1960). In animals, isolated sections of the gut of
hamsters show circadian rhythms of peristaltic activity 
(Bünning, 1973) , isolated eyes of the marine mollusc Aplysia 
californica a rhythm of optic nerve activity (Jacket, 1969) 
and isolated salivary glands from Drosophila melanogaster a 
rhythm in nuclear volume (Reusing, 19 69) .
In a natural 24-hour variation of light and temperature, the 
circadian system of an animal or plant, which is also 
oscillatory and with a near-24-hour period of its own becomes 
entrained to that of the environment in much the same way 
that two physical oscillators will achieve mutual entrainment. 
This entraining agent is commonly called a zeitgeber. When 
exposed to such an environmental zeitgeber the endogenous 
circadian oscillation adopts the exact 24-hour variation of 
the driver and also adopts a particular phase relationship to 
it. By achieving steady-state entrainment to the zeitgeber, 
an animal or plant can partition its activities with some kind 
of temporal order, and thereby perform behavioural and 
physiological activities at the 'right time of day.' Many 
animals, for example, restrict their locomotor and feeding 
activities to the hours of darkness (nocturnal), whereas others 
restrict their activity to the daylight hours (diurnal); still 
other animals are dusk-active, or crepuscular. The selective 
advantage of this behaviour may lie in the reduction of direct 
competition between, for example, diurnal and nocturnal species 
using the same food source.
There has been much debate as to whether circadian rhythms are
truly endogenous or exogenous. However, when organisms as 
diverse as unicellular algae, flowering plants, insects, birds 
and mammals are isolated and placed at constant temperature 
and in continuous darkness, and with all other possible 
zeitgebers, such as those caused by periodic human activity 
in the laboratory, excluded, the observed rhythms still 
persist, thereby revealing their endogenous nature. In the 
absence of the zeitgeber however, the rhythm 'free-runs' and 
the natural period,TV becomes either slightly less or slightly 
more than 2 4 hours. The value of TV is generally between 22 
and 2 8 hours, depending on the organism. Thus the rhythm may 
rapidly become out of phase with the solar day; for an 
organism whose is 2 3 hours, for example, the overt phase of 
the rhythm would occur one hour earlier each day, and would 
be 180° out of phase with environmental time within two 
weeks. In animals the range is generally between 23 and 26 
hours. The free-running period, however, is very rarely 
exactly 24 hours, and if it were one would suspect that a 
natural zeitgeber associated with the solar day had not been 
excluded. An interesting phenomenon has been observed when 
animals are kept in continuous light; the circadian rhythms 
persist but their period TV is altered. The studies led to a 
generality called ’Aschoff's rule' which states that the free- 
running period TV in nocturnal animals is longer in continuous 
light (and is increased still further if light intensity is 
involved) than in continuous darkness whereas in diurnal 
animals the situation is reversed. This rule is widely 
applicable to vertebrate species but finds some exceptions 
amongst insects.
Pittendrigh's work (19 54) on éclosion rhythm of Drosophila 
pseudoobscura focused attention on the phenomenon which is an 
essential functional prerequisite for a biological clock. He 
showed that the endogenous rhythm was temperature compensated. 
An oscillator which 'ran faster' as the temperature rose would 
be useless as a 'clock' and in the absence of compensation the 
period of the biological oscillator would at most temperatures 
fall outside the range of entrainment by the environmental 
zeitgeber and thus another important aspect i.e. control of 
phase would cease to function. Most physiological processes 
double their rate with a 10° rise in temperature yet the 
period of a circadian oscillator in its free-running state 
retains approximately the same value within a wide range of 
ecologically important temperatures. This effect seems 
strange when considering birds and mammals which have closely 
regulated 'core' temperatures and in which temperature 
compensation as such, might not be expected. A number of 
species of mammals have been subjected to deep hypothermia 
for varying periods and the effect of this treatment on their 
rhythms examined eg. in mice and hamsters, hypothermia down 
to 5° for 3-8 hours had little delaying effect on the activity 
rhythm (Rawson, 1960). This work suggests that this feature, 
important for chronometric purposes, is older in an evolutionary 
sense than the mammalian homeostatic temperature regulation.
The ability of organisms to adapt to external variations 
particularly solar or lunar rhythms has led to the idea that 
they possess some sort of timing mechanism. In particular.
the idea of an endogenous 'biological clock' which is 
responsive to and which can be synchronised, reset and 
otherwise modulated by environmental variations, such as that 
mentioned above, which the organism has encountered and to 
which it has adapted, throughout its evolutionary history.
The nature of this 'clock(s)' remains an enigma. Some workers 
suggest that the nucleus and protein synthesis are closely 
connected with the ciradian 'clock', whilst others believe 
that membrane physiology, cytoplasmic organelles, transcription 
along the DNA tape or high frequency biochemical oscillations 
are involved (see Edmunds, 1976 for review). Since true 
circadian rhythms have not been recorded from isolated sub- 
cellular particles or from cell-free extracts, it is probable 
that the 'biological clock' does not lie within the cell, but 
is the cell, the spatial integrity of the cell and interactions 
between organelles being essential for the special features 
of circadian variation. In a theoretical study, Winfree 
(1967) demonstrated how a population of oscillators, all 
with a similar fluctuation and a weak mutual coupling, tend 
to synchronise each other to a common phase and period, even 
though starting at random phase to each other. Perhaps it is 
in this way i.e. entrainment to a 24 hour environmental 
zeitgeber that all the constituent cellular oscillators 
achieve a mutual phase-relationship in multicellular organisms 
to provide whole-organism synchrony. This may explain why 
'free-running' can fade out after a few days or weeks; in the 
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Fig.I Circadian rhythm of endogenous 5 "  HT 
levels in the rat brain
The work presented here has not attempted to locate a 
'biological clock' but has investigated factors involved in 
the metabolism of 5-HT which could be capable of regulating 
the circadian rhythm of this amine in the rat brain. This 
influence itself may subsequently be controlled by a 'clock'. 
This may also provide more evidence about the way in which 
the functional activity of this neurotransmitter is controlled 
in the brain.
1.2 Evidence for a circadian rhythm of 5-HT in brain
A circadian rhythm in the concentration of 5-HT levels has 
been demonstrated in the whole brain of the mouse (Albrecht 
et al., 1956; Morgan and Undo, 1973), in the whole brain of 
the rat (Dixit and Buckley, 1967; Scheving et al, 1968;
Schwartz and Aghajanian, 1969; Okada, 1971; Asano, 1971 and 
Davies and Redfern, 1970), and the whole brain of the hamster 
(Matussek and Patshke, 1963) .
In whole rat brain, the highest concentration of 5-HT was 
found during the light period, and the lowest concentration 
during the dark period. This has also been confirmed in the 
work presented here (Fig. 1). A similar situation was also 
seen in brain regions of the rat e.g. the hypothalamus (Quay, 
1968; Eery et al., 1972), the cortex (Quay, 1965; Eery et al.,
1972) , the whole brain stem (Eery et al., 1972) , the lateral 
lower brain stem (Quay, 19 6 8), the mid-brain and caudate 
nucleus (Friedman and Walker, 196 8) and the amygdala and 
hippocampus (Scapagnini et al., 1972). In all these instances
1 0
the highest 5-HT levels were in the light period thus it 
would appear that the summation of the circadian effects on 
the concentration of 5-HT in the brain regions is responsible 
for the large fluctuation measured in whole brain. As whole 
brain measurements thus reflected levels in brain regions, 
the former was used as the tissue of study in this thesis.
1.3 Historical Introduction
Since the middle of the nineteenth century, scientists have 
been aware of a vasoconstrictor substance found in the serum 
of clotted blood which had the ability to cause powerful 
constriction of smooth muscle organs. Not until the mid­
twentieth century did scientists at the Cleveland Clinic in 
America succeed in isolating this substance as a possible 
cause of high blood pressure and gave it the name 'serotonin' 
(Rapport et al., 1948). The following year Rapport (1949), 
characterised the active moiety as 5-HT. When this compound 
was prepared synthetically by Hamlin and Fischer in 1951, it 
was found to behave exactly as the naturally occurring 
'serotonin?'
At the same time, Erspamer and his co-workers in Italy were 
trying to characterise the substance found in high concentrations 
in enterochromaffin cells of the intestinal mucosa. This 
material had the ability to cause constriction of smooth 
muscle, particularly the gut. The material isolated from the 
intestinal tract was called 'enteramine'. By 1946 Erspamer 
had proposed that the active component was an indolealkylamine
11,
but he was unable to characterise it further until 5-HT had 
been discovered in the blood. Erspamer and Asero (1952) 
then established that this was the chemical nature of 
'enteramine'.
1.4 The Occurrence of 5-HT
Indolealkylamines, including 5-HT, occur widely in nature 
for example, many types of fruit such as pineapples and 
bananas contain extremely large amounts of 5-HT. Also it is 
present in stings and verom e.g. common stinging nettles, 
wasps and scorpions. Mammals, birds, reptiles, amphibians, 
fish, tunicates, molluscs, arthropods and collentrates have 
all been shown to contain 5-HT. In mammals the highest 
concentration of this amine occurs in the pineal gland and 
in the enterochromaffin cells of the intestinal tract. In 
man, it is estimated that about 90% of the body's 5-HT occurs 
in the gastrointestinal tract, another 8 to 10% in platelets 
and only 2-5% within the central nervous system.
1.5 5-HT in the CNS
The studies of Amin et al., (19 54) were the first to show the 
existence of appreciable amounts of 5-HT in the brains of dog 
and also its uneven distribution. However, it was nearly ten 
years before scientists developed techniques to show that 5-HT 
in the brain was contained in neurons. The first support for 
this view arose from sub-cellular fractionation studies showing
5-HT and 5-hydroxytryptophan decarboxylase to be associated 













































































While this finding suggested only a general relationship to 
nerve terminals, two other techniques evolved which related 
5-HT to specific nerve tracts more closely. One technique 
involved combining neuro-anatomical lesioning with biochemical 
measurements and it was shown that lesions placed in the 
median forebrain bundle of the hypothalamus led to a dramatic 
fall in forebrain 5-HT concentrations over the next 5 to 12 
days (Heller and Moore, 1968).
The second technique of fluorescent histochemistry has 
perhaps achieved most in associating the amine with specific 
neurons. Barker and Pearse (Pearse,19 60) originally developed 
a fluorescent B-carboline complex (Fig. 2) from the addition 
of one molecule of formaldehyde to the 5-HT molecule. The 
method was adapted for the mapping of neurons containing
5-HT in the brain by the Swedish group of workers (for summary 
see Fuxe, Hokfelt and Ungerstedt, 1968). Unfortunately,
the fluorescence technique for 5-HT is not as sensitive as 
that for noradrenaline (NA) and dopamine (DA) but various 
modifications of 5-HT concentrations have been applied to 
emphasize 5-HT-containing neurons (Dahlstrôm et al., 19 73) , 
for instance, Aghajanian and Asher (19 71) used tryptophan 
(TRY) loading to increase 5-HT concentrations in neurons and 
consequently increase fluorescence. Also the fluorescent 
product developed after incubation of brain slices with
6-hydroxytryptamine has a greater intensity. Unfortunately,
6-hydroxytryptamine is non-specific i.e. it can be taken up 
by catecholaminergic neurons also. This can be overcome if
1 4
the latter are selectively destroyed first by pre-incubation 
with 6-hydroxydopamine (Farnebo 1971).
All these studies indeed provide evidence that 5-HT is 
contained within specific neurons in the brain. The 
ultrastructure of the nerve terminal is similar to that of 
catecholaminergic neurons. Both large and small dense core 
vesicles are present at least in the hypothalamus (Aghajanian, 
Bloom and Sheard, 19 69). Also the amine shorage granules 
appear to be of more than one type (Thierry, Fekete and 
Glowinski, 1968> Shield and Eccleston, 1972), and perhaps 
represent two forms, one important for release and the other 
for storage.
1.6 The Distribution of 5-HT in the CNS
The histochemical fluorescence technique and quantitative 
biochemical analysis mentioned previously have been used 
together with CNS lesioning to give much information on the 
mapping of 5-HT pathways. The principle of neurochemical 
lesioning was extended from the catecholamines, using
6-hydroxydopamine (Tranzer and Theoren, 19 6 7) to serotonergic 
neurons by the use of 5,6-dihydroxytryptamine (Baumgarten 
and Lachenmayer, 1972a; Nobin et al., 1973) and 5,7-dihydroxy- 
tryptamine (Baumgarten and Lachenmayer, 19 72b). These drugs 
cause acute degenerative changes in terminal ramifications 
and reactive changes in the preterminal portions of serotonergic 
neurons following their uptake. Preliminary data suggest 
that 5,7-dihydroxytryptamine is better tolerated in higher 
doses and that these doses cause greater damage than a
1 5







FIG. 3a. Schematic diagram of the central 5 - H T  neurons 




F IG .3 b. Schematic i l lustrat ion of subdivision of the
ascending 5 - H T  pathways
1 6
tolerated dose of 5,6-dihydroxytryptamine (Baumgarten et aL,
19 73b). 5-HT contained in the vesicles that accumulates 
proximal to the lesion may be better visualised while distal 
to the lesion, the nerve terminals and axons degenerate and 
the amine content falls.
These methods have shown that most of the cell bodies occur in the 
mid-brain (B7, B8, B9),pons (B5, B6) and medulla (Bl, B2, B3).
The nucleus raphe dorsalis (B7) is the largest 5-HT-containing 
raphe nucleus (Dahlstrôm and Fuxe, 1965; Hôkfelt et al.,
1973). These nuclei give rise to an ascending system of 
axons which begin to coalesce into a compact bundle at the 
level of the . interpeduncular nucleus (Ungerstedt, 1971).
The axons then occupy the most ventral part in the median 
forebrain bundle and may be separated into a medial and 
lateral component (Fig. 3). The lateral ascending 5-HT 
pathway primarily innervates the cortical areas and a minor, 
far-lateral pathway may exist which primarily innervates the 
extrapyramidal motor system. These pathways originate mainly 
from the mesencephalic raphe cell group i.e. B7, B8 and B9.
The medial ascending pathway is subcortical and innervates the 
hypothalamus and the pre-optic area. This pathway originates 
from the mesencephalic raphe (B7 and B8) and also the pontic 
raphe region (B5 and B6). The cerebellum innervation originates 
mainly from the mescencephalic raphe (B7 and B8) and possibly 
raphe cell groups (B5, B6) in the pons (Bloom et al., 19 72;
Fuxe and Jonsson, 19 74).
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The most caudal 5-HT cell groups in the medulla oblongata 
(Bl - B3) give rise to axons that descend in the medial part 
of the anterior funiculus and in the anterior part of the 
lateral funiculus to innervate the ventral horn and other 
axons that descend in the dorsal part of the lateral funiculus 
to innervate the dorsal horn and the symapathetic lateral 
column. (Carlsson et al., 1964; Dahlstrôm and Fuxe, 1965; 
Ungerstadt, 1971).
As stated previously, it is difficult to visualise 5-HT 
nerve terminals because of the insensitivity of the Falck- 
Hillarp technique. They have been mainly demonstrated in the 
nucleus suprachiasmaticus, globus pallidus, certain amygdaloid 
nuclei and in the ventral part of the lateral geniculate body 
(Fuxe et al., 19 68) . After treatment to increase the 
fluorescent intensity (discussed in section 1.5), very fine 
5-HT nerve terminals were observed in the septal area, in the 
anterior colliculi of the preoptic area, in the hippocampal 
formation and in the neo-and mesocortex. (Dahlstrôm and Fuxe, 
1964). With the use of 6-hydroxytryptamine (see section 1.5) 
it was possible to visualise a scanty 5-HT nerve terminal 
system in the nucleus caudatus putamen (Fuxe and Jonsson,
1974).
Biochemical microtechniques provide a significant advantage 
in precise quantitation of the amount of 5-HT present as 
estimates based on the intensity of the fluorescence observed 
under the microscope sometimes proved to be inaccurate.
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However, the former method gives no information about the 
nature of the structures containing the 5-HT i.e. neuronal 
cell bodies, terminals, axons or glial cells. Using 
biochemical methods, the areas found to contain the greatest 
amounts of 5-HT do agree with results from histofluorescence 
techniques. In the hypothalamus and preoptic area, high 
levels were detected in the nucleus suprachiasmaticus and 
the nucleus preopticus suprachiasmaticus. The limbic system 
was relatively rich in 5-HT particularly the amygdaloid 
nuclei. There was an eight-fold difference in this area 
between the lowest concentration in the hippocampus and the 
highest in the posterior medial forebrain bundle. In the 
rostral limbic system the highest 5-HT levels were found in 
the tuberculum olfactorium, the nucleus interstitialis striae 
medullaris and the nucleus interstitialis striae terminaiis.
In the brain stem high concentrations of 5-HT were found in 
the raphe nuclei and regions known to contain large numbers 
of serotonergic nerve terminals (e.g. motor cranial nerve 
nuclei, substantia nigra, globus pallidus). All three parts 
of the substantia nigra were strikingly rich in 5-HT 
compared with structures near them. 5-HT seemed to be evenly 
distributed between the various components of the reticular 
formation, amounts being moderate. Levels in the cerebellar 
cortex and nuclei were low (Saavedra, 1977).
1.7 Evidence for release and role of 5-HT synaptic transmission 
The localisation of synthesising enzymes and of 5-HT itself 
and the organisation of the nerve ending in this regard do 
suggest that 5-HT might be a neurotransmitter in the classical
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sense. The criteria established by Chang and Gaddum (19 33) 
for the role of acetylcholine as a neurotransmitter agent 
are here applied to 5-HT,
1. It should exert an action which elucidates its 
physiological role. In the CNS, this is a difficult 
criterion to meet. Certainly, when applied by microelectro- 
phoretic techniques to selected neurons, 5-HT exerts effects 
(Bloom et aL, 1972) , but whether those reflect its 
physiological effects is unknown.
2. It should be manufactured in the neuron. That criterion 
is met.
3. It should be destroyed by an enzyme present in nervous 
tissue. That criterian is met, and in addition it is now 
known that inactivation by reuptake into presynaptic nerve 
endings occurs (Snyder et aL, 1973).
4. It should be potentiated in vivo by factors which inhibit 
its enzymatic degradation in vitro; that criterion is met by 
the effects of monoamine oxidase (MAO) inhibitors.
5. It should be antagonised in vivo by specific chemical 
inhibitors. Certainly microelectrophoretic studies have shown 
that both lysergic acid diethylamide (LSD) and methysergide 
can block 5-HT responses by certain neurons, but both of 
these agents have pharmacological 'depressant' actions in 
their own rights (Bloom et aL, 19 73) .
The question to be asked is, "Does stimulation of a 5-HT 
neuron cause a release of 5-HT which then has a pharmacological 
effect (either excitatory or inhibitory) on the post-synaptic 
































direct evidence for such an effect.
In molluscs, 5-HT does appear to subserve a neurotransmitter 
role (Gershchenfield and Stefani, 1968) so a precedent is 
available. Electrical stimulation of brain slices 
undoubtedly causes the release of 5-HT (Chase et al., 1969). 
Also, perfusion of the lateral or third ventricle of a cat's 
brain with artificial cerebrospinal fluid (CSF) showed the 
appearance of 5-HT in the perfusate when the two most 
rostral raphe nuclei were stimulated electrically (Holman 
and Vogt, 1972; Ashkenazi et al., 1973). However, it cannot 
be certain that this has direct bearing on the question.
However, the experiments described in this thesis were 
designed on the assumption that 5-HT is a classical neuro­
transmitter; should this turn out not to be the case, many 
theories and speculations on the role of 5-HT in the brain, 
on the organisation of its synthesis and metabolism, and 
on the mode of actions of drugs will need total 
re-evaluation.
1.8 The Metabolism of 5-HT
Peripherally, the major route of metabolism of the amino 
acid precursor of 5-HT, TRY,is its oxidation to 
formylkynurenine by liver pyrrolase to form formylkynurenine 
and by formaraidation to kynurenine - the principal metabolite 
(Fig. 4). However, there is no evidence to suggest the 
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existence of kynurenine. Also TRY can be decarboxylated 
in the periphery to form tryptamine.
In the CNS, it has been established that 5-HT is synthesised 
by hydroxylation to 5-hydroxytryptophan (5-HTP) and 
decarboxylation to the amine. It is catabolised by MAO 
to the major excretory product 5-hydroxyindoleacetic acid 
(5-HIAA) (Udenfriend et al., 1956) (Fig. 5). The 
distribution of the enzymes necessary for 5-HT synthesis 
and breakdown closely follow that for 5-HT and are located 
in, or associated with nerve endings, axons and cell bodies 
which have been shown to contain the amine. This pathway 
is the major metabolic pathway of 5-HT and the investigation 
of the components of this pathway form a major part of 
the work presented in this thesis and are therefore discussed 
in greater detail in the following chapters.
However, alternative routes of metabolism do exist in the 
CNS and these are considered in the next section.
1.9 Other indoleamines in the CNS
1.9.1 Melatonin, 5-Methoxytryptamine and N-methylation
Any review of indoles other than 5-HT in the CNS has to 
include the indoleamine pathways in the pineal gland. This 
is something of a contradiction since the pineal is
2 4
cytologically outside the brain and its innervation comes 
not from the brain but from the superior cervical ganglion.
Its inclusion is necessary since anatomically it is 
closely associated with the brain and it appears to have 
close pharmacological connections, synthesising compounds 
which have been shown to alter brain function.
That mammalian pineal extracts will lighten amphibian skin 
has been known for many years. However, the active substance 
was not isolated until 1959, and was identified as 
5-methoxy-N-acetyTtryptamine or melatonin (Lerner et al.,1959).
The synthesis of melatonin is represented in Fig. 5. It 
appears to be controlled by the light-dark cycle. The activity 
of 5-HT-N-acetyltransferase increases in rats in the dark to 
15-70 times the daytime values (Klein and Weller, 1970;
Ellison et al., 1972). Exposure of rats to light results in 
a drop in activity of this enzyme, with activity halving in 
about 3 min. Physiologically it seems reasonable to relate 
this alteration in enzyme activity to control of pineal 
melatonin production and findings with pineal glands in 
organ culture suggests that both the production and the 
secretion of melatonin are controlled in this way (Klein 
and Weller, 1970; Klein et al., 1970,1971; Ellison et al.,
19 72). It is thought that the visual signals of the light- 
dark cycle regulate the release of melatonin and are thus 
converted to an endocrine signal (Wurtman and Anton-Tay,1969) 
that may have special importance in seasonal breeders such
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as the ferret, which becomes sexually active when the dark 
period is shortened (Herbert,1971). In other animals, it 
appears to have some fairly direct effects on the 
reproductive cycle. Implants of melatonin (Postini et al., 
1968) or perfusion of melatonin into the third ventricle 
(Kamberi et al., 1970) results in a stimulation of prolactin 
release and an inhibition in release of follicle- 
stimulating hormone (FSH) and luteinizing hormone (LH).
Several differences are evident in the hydroxylase enzyme 
in this system when compared to that of the brain. 
Hydroxylase activity in the pineal gland is unusually high 
(Lovenberg et al., 19 67) and work with p-chorophenylalanine 
(PCPA) has suggested that this compound does not inhibit 
the pineal enzyme directly, as in the brain, but competes 
for uptake with the substrate TRY (Deguchi and Barchas,
19 72). However, the enzyme is stimulated in pineal gland 
culture by addition of mescaline (Shein et al., 1971) 
which is consistent with the effects of this compound on 
whole brain. Another difference in 5-HT formation in the 
pineal gland is that constant lighting will increase 
decarboxylase activity (Snyder et al., 1965) although the 
physiological importance of this is not clear (Axelrod and 
Wurtman, 1968). Finally, the 5-HT in the pineal is 
localised differently from that in the brain, being present 
in both parenchymal cells and sympathetic nerve endings 
(Bertler et al., 1964), with 5-HT in these two compartments 
having different turnover rates (Neff et al., 1969b).
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The fact that hydroxyindole 0-methyltransferase (HIOMT) 
appeared to be unique to the pineal in mammals (Axelrod 
and Weissbach, 1961) precluded the formation of melatonin 
elsewhere. However, pineal HIOMT uses S-adenosylmethionine 
(Sa m ) as its methyl donor (Axelrod and Weissbach, 1961) and 
these workers used SAM as the donor when searching for 
HIOMT activity in the brain. Laduron (1972) has shown that 
5-methyltetrahydrofolic acid is the probable methyl donor in 
the conversion of DA to epinine in the adrenal medulla and 
this prompted Banerjee and Snyder (19 73) to investigate the 
possibility that this compound is also a methyl donor for 
5-HT in the CNS. They obtained significant 0-methylating 
activity. The product being 5-methoxytryptamine (5-MT). This 
is consistent with the observations of Green et al., (1973) 
who had already reported the presence of significant amounts 
of 5-MT in the hypothalamus using gas chromatography-mass 
spectrometry.
Having shown evidence of 0-methylation of 5-HT in the brain, 
there was considerable interest in the possibility of 
N-methylation of indoleamines, since some synthetic N-methylated 
indoles have been shown to be potent psychotomimetic agents, 
and abnormal N-methylation has been suggested to occur in 
certain mental illnesses (Szara, 1956; Pollin et al., 1961; 
Tanimukai et al., 1970; Mandell and Spooner, 1968). An 
indoleamine N-methyltransferase was shown to occur in chick 
and human brains (Morgan and Mandell, 19 69; Mandell and 
Morgan, 1971) and other mammalian tissues (Saavedra and
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Axelrod, 1972b). These experiments used the universally 
accepted methyl donor SAM, and enzyme activity was low.
Banerjee and Snyder (1973) using 5-methyltetrahydrofolate 
while finding significant 0-methylating activity as stated 
previously, found little evidence of N-methylation of 5-HT. 
Saavedra and Axelrod (1972b) however, after showing tryptamine 
to be present in the brain, demonstrated its conversion in rat 
and human brain to N-methyl and N,N-dimethyltryptamine.
Banerjee and Snyder (1973) confirmed this and also demonstrated 
0-methylation of 5-hydroxy-N-,N-dimethyltryptamine (bufotenin) 
to 5-methoxy-N,N-dimethyltryptamine (5-MeODMT)a potent 
psychedelic agent (Holmstedt and Lindgren, 1967). Bufotenin 
has been reported to occur in the plasma and urine of 
schizophrenics (Narasimhachari et al., 1971) together with 
5-MeODMT and N,N-dimethyltryptamine. However, since normal 
plasma also contains an N-methylating enzyme (Wyatt et al.,
19 73b) these compounds need not have originated in the CNS. If 
these compounds do occur in the CNS in certain pathological 
conditions, it is possible that their formation is suppressed 
in the normal state, and there is some evidence for this.
5-HT, catecholamines and histamine may inhibit tryptamine 
méthylation since they are substrates for the nonspecific 
methylating enzyme (Axelrod, 1961,1962) which has a specific 
distribution pattern in the brain (Saavedra et al., 1973) 
and S-adenosylhomocysteine, which occurs normally in brain, 
is reported to inhibit several methyltransferases (Deguchi 
and Barchas, 1971) and could thus in part control 
N-methylation in the brain.
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1.9.2 Tryptamine
Decarboxylation of TRY would produce tryptamine. The 
presence of high 5-HTP decarboxylase activity in the brain 
suggests that this compound could be present.
Bjorklund and Falck (1969) identified a tryptamine-like 
compound in the pituitary using histochemical techniques, 
and this was followed by the report of Martin et al., (1972) 
on the presence of tryptamine in normal steer, dog and human 
brain using gas chromatography and spectrophotofluorimetry. 
These workers were unable to find the compound in the normal 
rat brain. However, after development of a sensitive and 
specific enzymatic-radiochemical method (Saavedra and 
Axelrod, 1972a), tryptamine was demonstrated in normal rat 
brain (Saavedra and Axelrod, 1972b).
Iproniazid or TRY was shown to cause a small but significant 
increase in tryptamine, with a larger increase when both 
compounds were injected. PCPA also increased brain 
tryptamine, with a larger increase when TRY was given with it. 
These two drugs plus iproniazid increased tryptamine still 
further. Reserpine was without effect but a central 
decarboxylase inhibitor, NSD 1055, decreased levels by 40% 
and blocked the rise associated with iproniazid and TRY 
(Saavedra and Axelrod, 1973).
Similar results on the effects of MAO inhibitors, PCPA and 
reserpine were obtained by Marsden and Curzon (1974). Snodgrass
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and Horn (1973) showed that the spinal cord is richer than 
the brain in this amine and that concentrations increase 
rapidly after death. The brain tryptamine concentrations 
were highest in the hypothalamus and striatum and lowest in 
cerebral cortex and cerebellum.
Marsden and Curzon (19 74) commented that the absence of any 
parallel distribution of 5-HT and tryptamine argues against 
tryptamine being synthesised specifically in serotonergic 
neurons. This view was supported by their work using lesions 
and 6-hydroxydopamine which indicated that TRY was being 
decarboxylated to tryptamine in both serotonergic and cate­
cholaminergic neurons. They found no synaptosomal uptake 
mechanism for pH}tryptamine, which is consistent with the 
observation that intracerebrally injected tryptamine 
disappears rapidly from brain (Meek et al., 1970b) and that 
reserpine has no effect on brain tryptamine concentrations 
(Saavedra and Axelrod, 1973; Marsden and Curzon, 1974). The 
conclusions drawn from this work are that tryptamine is not 
formed in specific neurons and cannot be stored 
intraneuronally.
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1.10 The Role of 5-HT in Behaviour and Physiological Systems
1.10.1 Homeostasis ; autonomic functions.
a) Sleep
The first phenomenon shown to depend on the integrity of 
serotonergic neurons was sleep. Jouvet (1962) discovered that 
cats given PCPA exhibited a decrease in both slow-wave and 
paradoxical sleep followed by complete insomnia. The effect 
could be reversed by the administration of 5-HTP. The action 
of PCPA could be mimicked by destroying the raphe nuclei of 
the midbrain and pons.
If indeed 5-HT systems are involved in the production of 
sleep, the situation is not a simple one. Evidence suggests 
5-HT containing pathways interact with catecholamine pathways 
in the regulation of the sleep-waking cycle. Jouvet (1972) 
believes that NA rather than DA is involved in waking and 
paradoxical sleep. After raphe lesions when insomnia has 
developed and is almost permanent, a-methyl-p-tyrosine 
produces cessation of running movements, miosis and increased 
EEC cortical synchronisation, all of which last for 24 hours, 
after which there is a return to behavioural and ECG insomnia. 
Lesions of specific NA pathways produce hypersomnia during 
both slow-wave and paradoxical sleep, and this is accompanied 
by an increase in brain and spinal cord 5-HIAA, possibly 
suggesting increased 5-HT turnover.
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b) Temperature Regulation
In 1964, Feldberg and Myers suggested that cerebral 5-HT 
appeared to be involved in temperature regulation. They 
found that injection of 5-HT into the hypothalamus raised 
the temperature in the cat. It was then shown that 5-HT was 
released from the hypothalamus when an animal was cooled 
(Myers et al., 1969) They implanted a 'push-pull cannula' 
into the hypothalamus of a monkey and tested the effluent 
for 5-HT. The animal was subjected to a blast of cold air.
The 5-HT content of the perfusate rose by a factor ranging 
from 2 to 24. Myers and Waller (1975) microinjected 5-HT into 
the anterior hypothalamus and produced a release of 
acetylcholine (ACh) into the caudal hypothalamus. This 
strongly suggested that 5-HT release in the anterior 
hypothalamic preoptic area is involved in raising body 
temperature, possibly by triggering the activity of a 
cholinergic pathway which runs caudally in the diencephalon 
and mesencephalon, it was also observed that fever produced 
in a cat by bacterial pyrogen, or by intracerebro-ventricular 
injection of prostaglandin E, is much reduced after the 
administration of PCPA (Harvey and Milton 1974). From the 
evidence presented here, it appears that in the absence of 
serotonergic neurons an animal has difficulty in raising its 
body temperature. However, there are puzzling species 
differences in the role of 5-HT in temperature control.
Bligh et al., (1971) found that injection of 5-HT into the
lateral ventricle of sheep, goats and rabbits activated 
mechanisms of heat loss, not of heat production or preservation
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In view of the role of 5-HT containing neurons in 
temperature and sleep regulation it might be expected that 
they also play a role in hibernation. Inhibition of 5-HT 
synthesis in the ground squirrel by PCPA prevents hibernation 
and raphe lesions inhibit it either partially or completely. 
(Spafford et al., 1971). There has been no analysis of the 
multiple mechanisms involved.
c) Respiration
Many workers have experienced the difficulty of respiratory 
depression when anaethetizing a cat treated with an MAO 
inhibitor. The phenomenon appears to be due to the 
accumulation of 5-HT. Since it can also be produced by 
5-HTP and since the latter is active in the presence of an 
inhibitor of 5-HTP decarboxylase injected cerebroventricularly 
(Armijo and Florez, 1974). This effect may be an example, 
of the prevention by serotonergic neurons of excessive 
responses to sensory stimuli, carbon dioxide being the 
stimulus active in controlling respiration.
d) Vasomotor reflexes
Stimulation of the nucleus raphe obscurus caused a fall in 
blood pressure and a reduction of spontaneous and evoked 
sympathetic activity recorded from the white rami communicates; 
this reduction was mimicked by an intravenous injection of 
5-HTP (Neumayr et al., 1974). The pathway involved has its 
terminals on cells of the intermedio-lateral columns.
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1.10.2 Release of pituitary hormones
There is evidence for an inhibitory effect of 5-HT and 
therefore probably serotonergic neurons, on the liberation 
of a number of hypothalamic releasing or release-inhibiting 
factors. The demonstration of 5-HT and serotonergic terminals 
in the median eminence (Saavedra et al., 1974; Calas et al., 
1974) shows a possible morphological basis for such a function. 
As a result of administering 5-HT, the appearance in the 
blood stream of pituitary hormones is either increased or 
decreased, depending on whether their secretion is mainly 
controlled by a hypothalamic polypeptide which stimulates, 
or by one which inhibits secretion. Thus it has been shown 
that secretion of LH and FSH are suppressed while melanophore- 
stimulating hormone (MSH) and prolactin are enhanced by 
injection of 5-HT into the third ventricle or by administration 
of 5-HTP; the opposite effects follow treatment with PCPA. 
(Kamberi et al., 1970; Kamberi et al., 1971; Kordan et al., 
1973/74; Scheider and McCann, 1970; Taleisnik et al.,
1973/74; Chen and Meites, 1975).
The effect i.e. inhibition of 5-HT on the liberation of LH 
releasing factor was visualised by a fluorescent antibody 
reaction in the guinea-pig brain (Leonardelli et al., 1974). 
After intraventricular injection of 5-HT,sections of the 
preoptic and suprachiasmatic nuclei of the hypothalamus reacted 
with an antiserum to the releasing factor, thus producing 
fluorescent cells absent from the controls. The 
interpretation is that, when secretion of the releasing
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factor stops, it accumulates in the cells which manufacture 
it.
An inhibitory effect of 5-HT and 5-HTP has been observed 
on oxytocin release in the suckling rat (Mizuno et al., 1967) .
The exact site of action is not yet known. It is interesting 
that secretion of oxytocin and of prolactin are influenced 
by 5-HT in opposite directions.
However, the effects of 5-HT on the liberation of hypothalamic 
releasing or release-inhibiting factors again appears not 
to be a simple role. Taleisnik et al., (1973/74) showed that
not only the injection of 5-HT into the third ventricle but 
also that of&-aminobutyric acid ( GAB A) caused MSH release.
Both effects were inhibited by picrotoxin, a known GABA 
antagonist. The authors suggested a serotonergic neuron 
is in series with a GABA neuron which in turn inhibits, 
either directly or by presynaptic inhibition of an tonic 
stimulatory (adrenergic) system, the neurons producing MSH 
releasing inhibitory factor.
1.10.3 Motor Activity
Monosynaptic reflexes as well as spontaneous motorneuron 
activity are exaggerated and polysynaptic reflexes reduced 
by exogenous 5-HT (Anden et al., 1964; Anderson and Shibya,
1966; Barasi and Roberts, 1974), suggesting that the serotonergic 
axons in the cord contribute to the maintenance of normal 
spinal reflexes. Drug-induced motor abnormalities such as 
stereotyped behaviour or excessive restlessness after
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amphetamine and apomorphine are modified by lesions of 
the raphe nuclei (Costall and Naylor, 1974) and in an 
opposite direction by accumulation of endogenous 5-HT 
(Breese et al., 1974). Also if the brain 5-HT concentration 
is raised very rapidly by combining inhibition of MAO with 
either reserpine treatment (rabbits) or the administration 
of TRY (mice and rats) hyperactivity syndromes are observed 
(Brodie and Shore, 1957; Grahame-Smith, 1971a).
1.01.4 Behavioural responses
a) Convulsions
There are several examples of the ability of serotonergic 
neurons to 'normalise' behaviour, including responses to 
sensory stimuli. 5-HTP raises the threshold for audiogenic 
siezures in mice and also restores to normal the 
hypersensitivity to noise caused by reserpine (Boggan and 
Seiden, 1973). An increase or decrease in brain 5-HT 
concentrations respectively antagonises or facilitates 
electroconvulsive seizures and pentetrazole convulsions 
(Kilian and Frey, 1973). In keeping with this, the anti­
convulsant effects of phenobarital against these two forms 
of convulsions are diminished by PCPA and enhanced by 5-HTP 
(Meyerson and Lavander, 1970). However, the anticonvulsant 
effect of diphenylhydration was unaffected by changing the 
cerebral 5-HT concentrations.
b) Aggression
Mouse killing was elicited by lesioning the raphe nuclei in
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rats which previously remained indifferent to a mouse 
placed in their cage (Vergnes et al., 1973); similar effects 
were seen after treatment with PCPA (Sheard, 1969; Di Chiara 
et al., 1971). An important finding was that, however much 
PCPA was given, the aggressive behaviour was only seen in a 
percentage of the animals, showing the contributory rather 
than decisive role of serotonergic pathways.
Isolation-induced fighting in mice was found to be increased 
by lowering the 5-HT content of the brain with chloromethyl- 
amphetamine, and reduced by raising levels with 5-HTP and an 
inhibitor of peripheral decarboxylase.
c) Self-stimulation
Another instance of the role of 5-HT as an inhibitor of 
excesses in behaviour is shown with self-stimulation. 
Electrodes were implanted into the median forebrain bundle 
of rats and the rate of self-stimulation compared before and 
after either PCPA or 5,6-dihydroxytryptamine, both drugs 
used in doses which reduced the 5-HT content of the brain. 
Self-stimulation frequency was greatly enhanced by either 
drug at the time of lowest cerebral 5-HT concentrations 
(Poschel and Ninkeman,197l; Poschel et al.1974).
(d) Sexual behaviour
If PCPA is given to adult males, male to male mounting is 
observed (Schillito /1969 , 1970 ; Tagliamonte et al., 1969; 
Bond et al., 1972). The same phenomenon was seen when 
serotonergic neurons were damaged by 5,6-dihydroxytryptamine 
(Da Prada et al., 1972). It was also produced in cats
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(Hoyland et al., 1970); after receiving PCPA males mounted 
indiscriminately other males and anoestrous females. All 
effects were temporarily abolished by small, non-sedative 
doses of 5-HTP. It may be inferred that serotonergic neurons 
inhibit inappropriate sexual behaviour and, by their 
restrictive influence, limit mounting to biologically 
desirable circumstances. In females the effect is in the 
same direction but far less pronounced: PCPA caused the
occurrence of some aspects of oestrous behaviour in non- 
oestrous female cats (Hoyland et al., 1970) and an increase 
in lordosis and acceptance of the male in the rat (Everitt 
et al. , 1974; Meyerson and Lewander, 1970).
1.01.5 Response to different stimuli
a) Pain perception
Tensen (1968) first drew attention to the fact that the 
analgesic effect of morphine in the rat was reduced by PCPA.
A similar reduction was obtained by lesioning the raphe 
nuclei (Samarin, 1970). Electrical stimulation of the nucleus 
dorsalis raphe in the rat produces analgesia and this effect, 
too, is diminished by PCPA (Akil et aL, 1972). Activation 
of serotonergic pathways thus reduces pain, and part, at 
least, of the action of analgesic drugs is exerted with the 
help of such pathways. An attempt was made (Vogt, 19 74) to 
determine the location of the 5-HT containing fibres involved 
in this action of morphine. Rats were treated with a dose of 
5,6-dihydroxytryptamine which damages the spinal serotonergic 
axons severely and for a period lasting several months,while
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the effect on the cells of origin and all 5-HT containing 
neurons and on the ascending axons is slight (Baumgarten 
et aL, 19 72). This treatment only slightly reduced the 
analgesic potency of morphine, in contrast to the very 
pronounced effect of PCPA. The conclusion seems to be that 
the spinal serotonergic axons contribute to the analgesic 
effect of morphine, but are not the only ones involved.
b) Visual stimuli
The unusual density of serotonergic terminals in the superior 
colliculi of mammals prompted experiments on ways of 
activating these terminals. In vitro work (Kawai, 19 70) had 
shown that a thin slice of guinea-pig superior colliculus 
suspended in an organ bath can be loaded with (^H) 5-HT, 
and that the rate of release of radioactivity from the slice 
into the medium is accelerated by electrical stimulation of 
the optic tract. This raised the question whether, in vitro, 
stimuli would activate the 5-HT containing neurons terminating 
in the superior colliculus. Experiments were carried out on 
rabbits (Fukui and Vogt, 19 75) which have crossed optic nerves 
so that it was possible to try and effect only one colliculus 
by exposing one eye to visual stimuli. A rise in the tissue 
concentration of the metabolite of 5-HT,5-HIAA should 
indicate an increased turnover of 5-HT. A small, but 
significant increase in 5-HIAA content of the colliculus 
contralateral to the exposed eye was indeed found, whereas 
there were no differences in 5-HIAA content between other 
symmetrical parts of the brain taken from the right and left
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hemispheres. This increased turnover of 5-HT only occurred 
when the visual stimuli were not stationery, but moved, and 
when the moving flashes were as varied and irregular as 
possible. These are precisely the conditions which also 
elicit the largest and most constant electrical evoked 
responses in the superior colliculi. One is led to the 
conclusion that conditions which keep the colliculi very 
active in discharging stimuli to other parts of the brain 
(e.g. the visual cortex) are equally favourable to the 
discharge of serotonergic neurons. Exogenous 5-HT being 
invariably an inhibitor of the discharge of collicular cells, 
this seems to be another instance of the damping activity 
of serotonergic neurons to be called into action by excessive 
afferent stimulation.
C) Other environmental stimuli
Enhanced reactivity to novel environmental stimuli accompany 
lesions in the raphe nuclei. An attempt was made in the rat 
(Srebro and Lorens, 1975) to relate this behaviour abnormality 
to individual nuclei. It was found that destruction of the 
dorsal raphe nuclei, in spite of causing a loss of 65% of 
forebrain 5-HT, elicited hardly any change in behaviour, 
whereas lesions in the median nucleus, while reducing forebrain 
5-HT by only 36%, increased open field activity and responses 
to environmental changes.
Although it is not possible to give a common denominator to 
all physiological events in which serotonergic neurons
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participate, their most typical role appears to be one of 
preventing meaningless or excessive responses of the organism 
to environmental stimuli. The damping influence is 
particularly clear in the exaggeration, by loss of 5-HT, of 
male sexual behaviour, convulsive seizures, aggression and 
frequency of self-stimulation. 5-HT subserves certain 
analgesic pathways and seems to prevent over-activity in 
part of the optic system. Sleep also requires the integrity 
of certain serotonergic pathways. In view of the obvious 
importance of these neurons to our well-being a far greater 
knowledge is required for detecting or correcting their 
failure. The following section discusses the evidence for 
possible abnormalities in serotonergic function which may 
result in certain illnesses in man.
1.11 5-HT in mental illness and neurological disease
1.11.1 5-HT and Affective Disorders
Defective brain 5-HT metabolism in depression was first 
indicated by the low 5-HIAA concentration in lumbar CSF 
originally reported over a decade ago (Ashcroft et al., 1966) , 
and confirmed by most but not all subsequent studies (Goodwin 
and Past, 1975). Brain levels of 5-HT and 5-HIAA have also 
been reported to be lower in suicides than in control 
subjects (Pare et al., 1969 ; Asberg et al., 1976b).
Initially reports of this kind were taken to mean that 
defective brain 5-HT metabolism was solely responsible for 
some depressions in which case one might expect concentrations
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of 5-HIAA to rise on recovery. As this does not occur, it 
was suggested that recovery may involve increased sensitivity 
of 5-HT receptors rather than increased 5-HT metabolism 
(Medical Research Council, 1972).
Even if brain TRY and 5-HT metabolism are deficient in 
depression it does not necessarily follow that these 
biochemical abnormalities have any causative role; they might 
merely be harmless secondary consequences of the illness. 
However, a number of trials have indicated that TRY has anti- 
depressive efficiency comparable to various other more 
commonly used drugs. Coppen and coworkers (1967) reported 
that TRY was as effective as electroconvulsive therapy 
(ECT). Although there is disagreement on this, animal work 
(Green et al., 1977) suggests that the beneficial effect of 
ECT could itself involve increased responsiveness of post 
synaptic 5-HT receptors. Other workers have not found it 
was a useful antidepressant in the majority of patients 
treated (Carroll et al., 1970 ; Murphy et al, 1974), despite 
evidence that platelet 5-HT stores and possibly central 
5-HT turnover (estimated from the effect of probenecid on 
5-HIAA levels in CSF) were increased (Murphy, 19 72; Dunner 
and Goodwin, 1972).
While there is disagreement about the effectiveness of TRY 
as an anti-depressant, it is generally agreed that it 
potentiates certain other anti-depressants such as the 5-HT
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re-uptake blocker chlorimipramine (Walinder et al.,1975) and 
MAO inhibitors (Pare, 1963; Classman and Platman, 1969;
Coppen et al., 1963; Gutierrez and Alino, 1971). These 
results suggest that the therapeutic effects involve 5-HT 
or at least an amine formed from TRY, destroyed by MAO and 
released into the synaptic cleft. Administration of 5-HTP 
as an anti-depressant has a theoretical advantage over TRY 
as it is more readily converted to 5-HT but it also has a 
disadvantage because not all of this 5-HT is in serotonergic 
neurons. Large doses have been claimed to be directly 
beneficial in bipolar depressives (Sano, 1972) or to 
potentiate the MAO inhibitor, nialamide, when given to a 
mixed group of endogenous depressives (Alino, 1976). Infusion 
of 5-HTP into normal subjects, previously given a peripheral 
decarboxylase inhibitor, caused a rapid elevation of mood 
but such a response was noted in only a small proportion of 
depressives (Graw et al., 1976).
Perhaps, the most persuasive evidence of a causal role for 
a 5-HT defect in some patients with depression is that those 
who are helped most by 5-HT precursors appear to be deficient 
in 5-HT and distinguishable as a group on clinical grounds 
from other patients who are resistant to 5-HT precursors 
(van Praag and Korf, 1971; Asberg et al., 1976a).
1.11.2 Indoleamines and Schizoprenia
The theories which implicate indoleamines in the etiology of 
schizophrenia are derived mainly through consideration of
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the actions of psychotomimetic drugs and the relationship 
of some of these to indoleamine structures; the effects on 
the schizophrenic state of MAO inhibition and loading with 
TRY, methionine and cysteine; the neuropharmacological 
actions of phenothiazines in relation to their beneficial 
effect of schizophrenia; and, for monoamines in general, 
the implications of the 'paranoid schizoprenic synchrome' 
produced by chronic amphetamine usage.
However, the evidence to support these theories is in no way 
conclusive. Bradley et al., (1966) using microelectrophoretic 
studies suggested that chlorpromazine could exert its 
beneficial effects in schizoprenia by 5-HT receptor blockade. 
However, the ability of chlorpromazine to inhibit the actions 
of LSD, not only in animals but also in man, could be due to 
inhibition of dopaminergic pathways (Gordon, 1967). Green 
and Grahame-Smith (1974) proposed that dopaminergic pathways 
are probably involved distally in mediating the effects of 
the stimulation of certain 5-HT receptors which again cast 
in doubt the previous assertion that the phenothiazines act 
to block 5-HT receptors in vivo.
Metabolic evidence that there is either an abnormally high 
or an abnormally low rate of 5-HT turnover in schizophrenia 
is very unconvincing. Wyatt et al.,(1973a) have studied the 
effect on schizophrenia of administering 5-HT and a peripheral 
aromatic acid decarboxylase inhibitor. The drug combination 
was better than placebo in at least seven patients and in
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two there was no difference; however, two patients became 
worse on the treatment.
The effects of 'precursor loading' in schizoprenia are also 
difficult to interpret. Pollin et al., (1961) administered 
various amino acids together with a MAO inhibitor to 
schizophrenic patients. TRY caused euphoria and a freeing 
of associations, while methionine caused increased anxiety, 
tension and motor activity, depression, increased 
hallucinatory activity and periods of disorientation with 
agitation. In general, these findings with methionine have 
been confirmed (Grahame-Smith, 1974; Smithies, 1974). A 
hypothesis for the worsening of the schizophrenic state was 
that methionine acts as a methyl donor, via s-adenosyl- 
methionine, to methylate an indoleamine and thus produce an 
endogenous psychotogen. The increasing evidence that 
N-methylated tetrahydrofolate may be the methyl donor for 
the indoleamine N-methyl transferase in brain weakens this 
hypothesis (this is further discussed in section 1.9.1). 
Several workers have looked for N-methylated indoleamine 
derivatives in schizophrenic and normal subjects but results 
are confusing (see section 1.9.1).
In summary, although there is no firm evidence of either a 
dysfunction in serotonergic pathways or the endogenous 
production of an indoleamine psychotogen in schizophrenia 
there are a number of leads to support continued investigation 
in this field.
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1.11.3 5-HT and Mongolism
While it is well established that there are abnormalities 
in TRY metabolism in mongolism (Down's syndrome), there is 
sti^l little information on the central indoleamine changes 
because of the difficulty of studying human brain metabolism 
and the lack of an adequate animal model. It has been shown 
by many workers that platelet 5-HT is below normal at all 
ages of mongolism (Posner et al, 1965; Tu and Zellweger,
1965; Boullin and O'Brien, 1971; Airaksinen, 1971). Urinary 
5-HIAA excretion is increase in mongoloids (Airaksinen,
19 71) but total 5-hydroxyindoles in CSF are normal* Studies 
on plasma TRY (Airaksinen and Airaksinen, 19 72) showed 
normal fasting TRY but a smaller rise in mongoloids after 
TRY loading compared to normal children. The binding of 
TRY to plasma proteins in mongoloids is lower than normal 
(Airaksinen and Airaksinen, 19 72) which might affect brain 
5-HT synthesis.
A very different approach has been used to determine whether 
central 5-HT metabolism is abnormal in mongoloids by 
utilising the hypothesis that the platelet might be used as 
a model for the serotonergic neuron in the brain (Passonen, 
1968; Pletscher, 1968). 5-HT uptake and binding in platelets 
from mongoloid and normal subjects was studied. Concentrations 
of endogenous 5-HT in mongoloid platelets were 25% of normal 
and net 5-HT accumulation was 50% of normal. Furthermore, 
efflux from 5-HT loaded platelets was much greater from 
mongoloid than from normal platelets. It was considered
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that the low 5-HT in mongoloid platelets was due to defective 
transport and impaired binding, the latter resulting from 
the reduction of adenosine triphosphate (ATP) concentration 
also observed in these platelets (Boullin et aL, IS69;
Boullin and O'Brien, 1971). These authors also found 
decreased MAO activity in mongoloid platelets (Boullin and 
0 'Brien, 1973).
Clearly, further work on the CNS is needed since there is 
probably little more to be gained from peripheral studies. 
Boullin (1975) measured 5-HT in the postmortem brain of one 
mongoloid child and found evidence of decreased 5-HT 
concentrations but this cannot be accepted as definite proof 
until there are further studies and appropriate controls.
Many of the functions that 5-HT is suggested to control or 
modulate in the brain do not appear to be overtly impaired 
in mongoloids, and thus it remains to be determined whether 
central 5-HT metabolic abnormality has a primary role in the 
manifestations of Down's syndrome.
1.11.4 5-HT and Phenylketonuria
Phenylketonuria is an inborn error of metabolism in which 
there is a failure of the liver to hydroxylate phenylalanine 
to tyrosine. The plasma concentration of phenylalanine is 
therefore 20-40 times higher than normal and abnormal 
metabolites appear in the urine. The most obvious clinical 
result is severe mental retardation.
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The demonstration that serum 5-HT and urinary 5-HIAA 
concentrations were decreased in phenylketonuria (Pare et al., 
1957, 1959) led to animal studies on indoleamine changes in 
animals fed a high - phenylalanine diet. It appeared that 
most changes in both peripheral and central 5-HT were 
probably due to an effect on TRY transport. Yarbrp and 
Anderson (1966), for example, found defects in TRY uptake 
from the gut of phenylketonurics, this change being reversed 
by giving a low-phenylalanine diet. Similar inhibition 
probably inhibits uptake of TRY into brain slices (Grahame- 
Smith, 19 68; Green and Curzon, 19 70) and synaptosomes 
Grahame-Smith, 1968). Brain 5-HT was decreased in rats 
given a high-phenylalanine diet, but there was no correlation 
in their performance in various tests and the brain 5-HT 
concentrations (Yuwiler and Louttit, 1961). Nor was there 
any improvement in phenylketonuric children given 5-HTP or 
MAO inhibitors to increase brain 5-HT, and it is now generally 
considered that the changes in central 5-HT metabolism in 
phenylketonurics are not responsible for the mental 
impairment or pathogenesis of the disease.
Considering the evidence presented in this introduction for 
the physiological role of 5-HT in the CNS and its possible 
involvement in certain disorders, it is important to 
understand the controlling mechanisms of the functional 
activity of serotonergic neurons. It is hoped that by 
studying the possible biochemical factors controlling the 
circadian variation in 5-HT concentrations in the rat brain, 






Within any laboratory or animal house, the normal 
environmental conditions vary daily and annually with 
respect particularly to lighting, temperature and noise 
levels. In any animal experiment it is necessary to control 
these variables and it is especially important to maintain 
a controlled environment when estimating circadian 
fluctuations as there is evidence to suggest that 5-HT levels 
and metabolism in the brain are susceptible to environmental 
changes (Hauty and Adams, 1966a, 1966b; Schwartz and 
Aghajanian, 1969; Thierry et aL, 1968). For these reasons, 
specially constructed cabinets were used to house the rats, 
(described in Section 2.2). These also had time clocks 
fitted to enable the experimenter to work during 1:he normal 
period of a day and thus to avoid circadian changes in the 
performance of the experimenter.
2.2 Cabinet Construction
Fig. 6 is a photograph of the cabinets used in these 
experiments. The cabinets were made from 6/10 in. blockboard 
and the dimensions of each are 18 x 24 x 48 ins. Lighting 
was supplied to each cabinet by a 12 in. miniature 
fluorescent fitting with an 8 watt, warm white tube (Thorn,L.J 
SI008 H). To prevent overheating the choke was removed from 
each fitting and reassembled outside the cabinet. Each light 
was connected through a time switch (Sangamo Type 5254-1-171). 




glued to the perimeter of the inner door face and its 
adjoining surface. Sound insulation of each cabinet was 
improved by a lining of \ in. polystyrene sheeting. The 
problem of ventilating and maintaining the environment at 
a constant temperature was overcome by using domestic 
extractor fans (Xpelair FXC 6) to draw a constant flow of 
air through the cabinets. One fan, which was capable of 
removing 1,200 cu. ft. of air per hour served four cabinets, 
to which it was connected through triple gauge 1 1/4 in. 
bore rubber tubing. The intake was first passed through an 
insulated chamber containing a 3 00 watt infra red bulb.
This was activated by a thermostat inside the cabinet so 
that in the event of a fall in temperature inside the 
cabinet, the temperature of the air input was automatically 
increased. A constant watering device was fitted and by 
using extra large food hoppers on the cages, animals (in 
groups of five or three) could be left undisturbed for up to 
fourteen days.
The characterisation of the cabinets i.e. light proofing, 
sound proofing and temperature variation had been previously 
investigated (Hillier et al«, 1973) and found completely 
satisfactory. For this reason the work was not repeated for 
this thesis.
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2.3 Choice of animal
Male CFY rats were used throughout the experiments
described. Rats were chosen for the following reasons:-
(a) Economy, availability, ease of maintenance, handling 
and use.
(b) Strains of this species are the most standardised 
animals available to the laboratory investigator due to 
inbreeding and also the most widely studied in 
pharmacology (Woodward, 1965) thus providing a balance 
between control of variation and applicability of results
2.4 Maintenance of animals
Male CFY rats (100-120g) were kept in groups of five 
(biochemical analysis) or three (behavioural work), with one 
group per cabinet. The rats had access to food (Oxoid 
Breeding Diet) and water ad libitum and could remain 
undisturbed for up to fourteen days.
As stated previously, experiments were performed during the 
normal working period of the operator which meant that many 
of the rats had to undergo a phase shift upon entry to the 
cabinets. At least ten days were therefore allowed for 
re-adjustment and acclimatisation for all groups of animals 
(Davies et aL, 1974). There was no recognisable difference 
between groups of animals maintained on a 'normal' lighting 
regimen and those on the reversed schedule. Weight gain, 
weight of food consumed and volume of fluid intake were all
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similar.
The animals were always maintained on a 12 hour light:
12 hour dark cycle and temperature was maintained at 
24 + 1.5^C throughout. When the animals had to be killed 
or injected during a dark phase, the laboratory was 
illuminated only by a photographic red safety lamp, since 
red light has been shown to have no significant effect on 
circadian variation (McGuire et aL, 1973) .
CHAPTER THREE
The 2 4-hour variation in total, 
'free' and bound TRY in the rat brain
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3.1 Introduction
TRY is one of the essential amino acids in the body. It is 
also the precursor for the putative neurotransmitter, 5-HT 
Many factors influence the level of TRY in the blood and brain 
and the relevance of these will be discussed in terms of 
affecting 5-HT synthesis in serotonergic neurons in the brain.
The daily flux of amino acids in the body is extensive. About 
300g of protein is synthesised each day in an adult man. This 
requires the uptake and release of 150g of essential amino acids, 
yet the minimum dietary requirement for essential amino acids is 
only 6g while the customary diet contains 45g (Munro,1972b).
This indicates considerable and efficient recycling of the 
essential amino acids released by protein breakdown. One reason 
for this is the restriction of key catabolic enzymes of 7 of the 
essential amino-acids to the liver (Miller, 1962). Consequently, 
considerable amounts can be reused for protein synthesis within 
cells providing these amino-acids do not leak into the blood in 
large amounts and reach the liver.
After a meal rich in protein, the amount of free amino acids 
in the portal vein can rise considerably during the absorptive 
phase, whereas their concentration in the systemic circulation 
changes much less. Studies on dogs having cannulae in the 
blood supply to and from the liver show that this is due to the 
enormous capacity of the liver to remove amino acids from the 
portal vein and thus regulate their flow into the systemic 
circulation (Elwyn, 1970).
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In humans, plasma TRY and most other amino acids exhibit 
characteristic fluctuations every day reaching a peak mid - 
afternoon if the subject is on a standard mealtime schedule 
(Wurtman et a 1,^ 1968,* Wurtman, 1970) . A similar rhythm was 
subsequently noted in rats for plasma TRY but the peak was 
reached in the dark period (Fernstrom et al.^ 1971). This 
phenomenon was attributed to the rat's tendency to consume 
most of its food during the hours of darkness.
Approximately 70% of TRY is oxidised by tryptophan pyrrolase 
in the liver to formylkynurenine. This enzyme displays a 
24-hour variation in activity and it has been suggested this 
could control the rhythm in plasma TRY. (Rapoport et al.^1966) . 
Young and Munro (1973) showed that TRY levels in plasma and 
the activity of liver tryptophan pyrrolase increased only 
when basal dietary TRY requirements were exceeded indicating 
an adaptation of the enzyme after a meal. However, Ross 
et al.^ (1973) found that whereas tyrosine aminotransferase 
was rapidly activated by protein consumption, tryptophan 
pyrrolase was unaffected. Nonetheless, it was noticed that 
pyrrolase activity reached a peak around the time of day 
that the rats ate. Thus, while the enzyme may not be 
activitated by TRY it seemed to be active at the appropriate■ 
time of day. Intact adrenocortical function is required for 
expression of a normal rhythm of both pyrrolase and TRY 
although an altered and less apparent rhythm persists in 
:he adrenalectomised state (Rapoport et al,^ 1966) indicating 
:hat enzyme activity is under hormonal control. Joseph et al.,
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14(1976) showed that the amount of CO^ exhaled quadrupled 
after injection of a tracer dose of {2-^^C}TRY if 5mg/kg 
cortisol had been injected 150 mins previously. This increase 
was proportionately at least as great as the increase in 
kynurenine synthesis from TRY by liver tissue in vitro.
The mere existence of rhythms in plasma concentrations 
of amino acids did not establish that such variations were 
of any consequence physiologically. The plasma rhythms in 
humans persisted for two weeks in volunteers who.ate 
essentially no protein (Wurtman et al.^1968) yet disappeared 
in subjects on a total fast (Marliss et al^l970); this 
finding suggests the rhythms are not truly circadian or of 
endogenous origin and that the most important factor in 
their genesis is nutritional. The significance of these 
rhythms was further explored by determining whether the 
metabolic fate of an amino acid could be influenced by daily 
fluctuations in its plasma level. Intraperitoneal injections 
of TRY which change plasma,TRY concentrations by an extent 
smaller than the circadian variation were found to produce 
a significant rise in brain 5-HT levels (Fernstrom et al.,1971) 
Experiments were then carried out to determine whether 
physiological decreases in plasma TRY could decrease amine 
content. Insulin reduces almost all other amino acid levels 
in plasma by enhancing their uptake into skeletal muscle 
(Wooljl965). However, Fernstrom and Wurtman (1972a) found 
insulin increased plasma TRY levels by 30-40% and also
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increased brain TRY and 5-HT levels whether injected or 
by secretion elicited by a carbohydrate diet fed to fasted 
rats. It was predicted that a diet of carbohydrate plus 
protein would raise 5-HT levels still further (Fernstrom 
and Wurtman /19 72b). This was not the case; plasma TRY 
levels rose sharply but brain TRY and 5-HT levels were 
unaltered. If the amount of protein in the meal was increased 
beyond the 18-22% contained in most commercial rat chows, 
brain TRY and 5-HT could even fall.
Other investigators, using brain slices (Blasberg and Lajtha , 
1965) or animals treated with pharmacological doses of 
individual amino acids (Guroff and Udenfriend,l962) had 
shown that groups of amino acids (e.g. neutral, acidic and 
basic) are transported into the brain by specific carrier 
systems, and that within a group, the member amino acids 
compete with each other for common transport sites. Fernstrom 
and Wurtman explained their results in terms of the ratio of 
plasma TRY to the other neutral amino acids (tyrosine, leucine, 
phenylalanine, valine and isoleucine). ' Since carbohydrate 
ingestion elicits insulin secretion, it simultaneously raises 
plasma TRY and lowers the concentration of the competing amino 
acids leading to elevations in brain TRY. In contrast, 
virtually all natural proteins contain less than 1.5% TRY but 
more than 25% of their total mass derives from the five 
competing amino acids (tyrosine, leucine, phenylalanine, valine, 
and isoleucine). Moreover tryptophan pyrrolase catabolises
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a considerable fraction of TRY entering the liver via the 
portal vein while little or no metabolism of the branch- 
chained amino acids (leucine, isoleucine and valine) occurs 
in the liver. Hence, the consumption of any protein causes 
proportionately greater increases in the plasma concentration 
of tryptophan's competitors than in that of TRY itself. This 
was verified when the same diet minus the five neutral amino 
acids increased brain TRY and 5-HT. Removal of aspartate 
and glutamate, 2 amino acids using a different amino acid 
transport system from TRY failed to alter brain TRY and 5-HT 
concentrations. These results show that brain TRY and 5-HT 
levels do not singly reflect those of plasma TRY but depend 
also upon the plasma concentrations of the other neutral amino 
acids.
However, these studies measured total plasma TRY and did not 
take into consideration the unusual property of TRY, its 
ability to bind to serum albumin. About 10-20% circulates as 
the free amino acid (McMenamy et al., 1957) . No other amino
acid binds appreciably to plasma proteins. Because binding 
in general implies storage, several investigators have 
suggested that the plasma free TRY is the functionally 
important pool in determining the availability of circulating 
TRY to brain and other tissues (Knott and Curzon, 1972) . This 
hypothesis was tested by a study of the effects of 2 
environmental manipulations- immobilisation stress and food 
deprivation (Curzon et al., 1972). Both treatments
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significantly increased brain TRY and 5-HT turnover as 
indicated by increased 5-HIAA but did not increase brain 
amino acids generally (Knott et al., 1973). It seemed that 
brain TRY changes were generated by changes in plasma.
However, brain TRY increased while plasma TRY levels remained 
constant. This anomaly was clarified when both total and free 
plasma TRY were determined. It was found that the increase of 
brain TRY was associated with a shift in equilibrium between 
free and bound TRY so that the free material increased. One 
way in which the equilibrium can be altered is by non- 
esterified fatty acids (NEFA), which are almost completely 
bound to albumin. When fatty acid concentrations rise, plasma 
TRY is freed and made more available to the brain. Food 
deprivation and emotional stress are known to increase plasma 
NE7A (Dole, 1956; Mallov and Witt, 1961) and free TRY levels 
rise if fatty acids e.g. linoelic, oleic and palmitic acid 
are added to plasma in physiological concentrations (Curzon 
et al., 1973). These results suggest that many agents which 
affect lipolysis and plasma NEFA concentrations (Fig. 7) 
by acting on fat cell cyclic AMP could Influence the 
diiposition of plasma TRY and thus 5-HT turnover in the brain. 
Caiecholamines certainly alter plasma NEFA levels. Havel and 
Go.dfien (19 59) demonstrated that NA increased plasma NEFA 
coicentrations presumably through an action on 3 receptors since 
iscprenaline had the same effect.
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Both these treatments raised free TRY levels as did injection 
of L-dihydroxyphenylalanine (L-DOPA) at high doses (Curzon 
and Knott, 19 74). Previous reports had stated that intravenous 
infusion of L-DOPA into dogs increased plasma NEFA 
(Rivera-Calimlin and Bianchine^1972) and that L-DOPA injection 
into rats increased brain TRY concentrations (Weiss et al.,1971) 
The phosphodiesterase inhibitor aminophylline also increased 
plasma NEFA levels and therefore as expected, increased plasma 
free TRY and brain 5-HT turnover. While nicotinic acid only 
caused a small plasma NEFA decrease in fed rats, it did 
abolish the rise in NEFA levels that occurred during food 
deprivation. It thus almost totally abolished the changes in 
plasma and brain TRY and brain 5-HT turnover that occurred 
during deprivation (Curzon and Knott,1974).
The effect of drugs have also been used to investigate whether 
those which increase serum free TRY increase brain TRY and 5-HT 
levels and vice versa. Salicylate, probenecid and clofibrate 
vhich are able to release TRY from its binding to serum 
albumin (McArthur and Dawkins , 19 69 )are capable of increasing 
brain TRY levels (Gessa and Tagliamonte, 19 74) . Of the 
zreatments that stimulate synthesis of 5-HT for instance 
D-amphetamine, reserpine, lithium carbonate, adenosine 
3'5' monophosphate (cyclic AMP) and electroconvulsive shock 
only D-amphetamine and lithium significantly increased the 
unount of serum free TRY and neither compound released TRY 
from its protein binding when added in vitro. It would
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appear that changes in free plasma TRY affect brain TRY 
and 5-HT levels rather than the opposite way round. All 
these studies would suggest that changes in free plasma 
TRY levels reflect similar changes in brain TRY and 5-HT 
levels. However, an experiment using streptozotoxin, a 
drug which destroys the pancreatic cells that secrete 
insulin(Arison et a1^1967) thereby decreasing plasma insulin 
concentrations, raised plasma NEFA levels and free TRY 
concentrations but brain TRY did not alter. (Fernando 
et al.,1976). This implied that lowered insulin levels 
resulted in a decrease in the effectiveness of TRY uptake 
into the brain as the level of competing amino acids was 
unaltered. Another piece of evidence supports the conclusion 
that both plasma TRY binding and competing amino acids 
influence brain TRY concentration. Etienne et al.) (1976) 
examined the uptake of TRY into the brain using the 
technique of Oldendorf (1971). The uptake of radioactive 
TRY injected into the carotid artery was diminished both by 
addition of albumin and by addition of competing amino acids. 
Addition of albumin did not alter uptake of tyrosine, which 
is not albumin bound.
As stated there are many factors which can influence free 
TRY availability to the brain such as plasma NEFA concentration, 
the concentration of neutral amino acids competing for uptake 
into the brain, responses at ot and 3 receptors and the 
activity of tryptophan pyrrolase. Much of the work has
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involved pharmacological manipulations of TRY levels in the 
blood, which depending on the circumstances i.e. the 
relative contribution of the factors mentioned previously, 
may lead to an increase in brain TRY. In situations when 
brain TRY levels do rise, in general, there is a concurrent 
effect upon 5-HT and/or 5-HIAA concentrations. Tpis is 
thought to be due to the fact that tryptophan hydroxylase, 
the rate-limiting step in the synthetic pathway, is 
unsaturated with substrate under normal physiological 
conditions (this is discussed further in Chapter 5). The 
possibility of the regulation of 5-HT synthesis via brain 
TRY concentrations under normal physiological conditions, 
however, must be questioned when considering the circadian 
rhythms of 5-HT and TRY concentrations in the rat brain. 
Serum free TRY and brain TRY levels reach their peak values 
in the dark period (Fernstrom and Wurtman,1971 ; Hery et al., 
1972)which corresponds to the animals' peak feeding activity 
while 5-HT concentrations are highest in the light period 
(discussed in Chapter 1). This 180° phase difference would 
be extremely difficult to explain if the assumption that
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brain TRY levels controlled 5-HT synthesis were true, 
particularly as previous findings in our laboratories had 
shown that the 24-hour variation in 5-HIAA levels closely 
followed that for 5-HT i.e. 5-HT levels were not low in the 
dark phase because turnover was high.
In these circumstances it appeared that endogenous TRY 
concentrations do not control the 24-hour variation of 5-HT
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levels. However, the TRY estimations for the circadian 
variation were of total brain TRY levels. I thought as 
serum free TRY levels invariably reflect brain TRY levels 
perhaps the same criterion is relevant in that only 'free' 
TRY in the brain is the source of substrate for tryptophan 
hydroxylase. For this reason an experiment was devised 
to measure the levels of total, bound and 'free' TRY in 
the rat brain over 24 hours.
3.2 Method
The assay used to determine levels of total, protein bound 
and 'free' TRY in the rat brain involves the formation of the 
fluorophore norharman, from TRY by condensation with 
formaldehyde and then oxidative decarboxylation with 
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levels in plasma, urine and liver.
3.2.1 Preparation of samples
Male CFY rats (l80-220g) were killed by decapitation, the 
brains rapidly removed and the pineal glands discarded.
After weighing, each brain was homogenised in 3mls ice 
cold 0.9% saline (pH 7.4), and each homogenate divided in 
two. To one fraction, 1ml of 75% trichloroacetic acid 
(TCA) was added and after thorough mixing this sample was 
used to measure total brain TRY levels. 1ml of 0.9% saline 
was added to the remaining fraction and this was used for 
'free' TRY estimations. This procedure was repeated 4 times 
but the volume of the homogenisation medium (8mls,13mls,
I8mls and 2 3mls) was increased each time, thus altering the 
equilibrium between the 'free' and bound TRY. The ratio 
between each successive increase in homogenisation medium 
volume was inversely proportional to the final concentration 
of TCA.
3.2.2 Estimation of 'free' TRY in rat brain.
The samples were centrifuged for 15 mins at lOOOg at 4°C, 
the supernatants decanted off and 1.5ml aliquots pipetted 
into centriflo CF50A filter cores (Fig. 8 ) previously 
prepared by soaking for 1 hour in distilled water. These 
filters have >95% retention for molecules above 50,000 MW, 
thus protein will be retained. The cones plus their supports 
were centrifuged for 30 mins at l,000g at room temperature 
(excessive g force will cause protein leakage and may burst
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F ig . 9 Summary o f the method used to  measure to ta l  and ' f r e e ' 
TRY in  the ra t  b ra in .
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the filter) . lOOjil aliquotè of the ultrafiltrates were
added to 0.9ml distilled water, 1.8ml 10% TCA (w/v)
-4containing 3 x 10 M FeCl^ and 0.2ml 1.8% formaldehyde 
in a test tube and the contents mixed. After stoppering, 
the tubes were placed in a water bath for 1 hour at 99^C 
to lOl^C. Temperatures below 99°C seriously affected the 
yield. Following the reaction, the tubes were cooled 
to room temperature and the product read at excitation and 
emission wavelengths of 290nm and 450nm respectively in a 
quartz cuvette in an Aminco-Bowman spectrophotofluorimeter. 
Since the change in fluorescence of norharman 
is negligible between 22° to 3o°C, no special cooling is 
necessary. An internal standard of lOOng of TRY was 
prepared for each sample and reagent blanks were prepared 
by replacing the 100 p.1 sample with lOOjil 0.9% saline.
3.2.3 Estimation of total TRY in the rat brain 
The protein-precipitated samples were centrifuged at 
20,000g for 20 mins at 4°C. lOOj^l aliquots of the 
supernatants were made up to 1ml with distilled water and 
mixed with 1.8ml 10% TCA (w/v) containing 3 x 10 FeCl^ 
and 0.2ml 1.8% formaldehyde. Resulting solutions were heated 
at 99°C to 10l°C for 1 hour, cooled to room temperature and 
read at excitation 290nm and emission 450nm. Internal 
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This standard method was arrived at after experiments were 
carried out to determine the optimal conditions for the 
assay. These experiments and their results are described 
in section 3.3. This method then formed the basic 
procedure for the determination of total, bound and 'free'
TRY in the rat brain over 24 hours.
3.2.4 The 24-hour variation of total, bound and 'free' TRY 
in the rat brain.
Male CFY rats (l80-220g) were maintained on a 12 hour light:
12 hour dark cycle for 14 days as described in Chapter 2 
and then killed by decapitation at 4 hourly intervals. The 
brains were removed and prepared as described in section 3.2.1 
with one exception i.e. the homogenisation medium volume was 
kept constant at 13ml. 'Free' and total TRY were determined 
as described in sections 3.2.2 and 3.2.3 and bound TRY 
values were calculated as the difference between the total 
and 'free' TRY concentrations.
3.3 Results
Expt. 1 Standard curve for L-TRY in the presence of increasing 
concentrations of perchloric acid.
Standards (1-5 \ig TRY in a final volume of 4mls) were heated
for one hour at 99° to 101°C with 0.1ml 85% TCA (w/v)
— 2
containing 10 M FeCl^ and 0.1ml 18% formaldehyde, and read 
at excitation 370nm and emission 450nm. Fig. 10 shows when 






































o o o o O o O Oo o o o O o O Oo o o o O o O O



























































ACT. 2 9 0  nm
EM. 4 5 0  nm7 0 0 0
6 0 0 0
5 0 0 0
4 0 0 0
a c t . 3 7 0  n m  
EM. 4 5 0  nm3 0 0 0
O O O
3O 2 4
>jg (in sample) L - T R Y
Figure 12 The effect of TCA i'\0%) on the relative fluorescence
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Figure 13 The effect of 2.5 x '[O M  FeCi (final conc^) on the relative 
fluorescence of norharman (in O.^N HCl): emission 450nm; 
activation 290nm^ 370nm.
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perchloric acid instead of distilled water, the relative 
fluorescence values are decreased.
Expt. 2 Standard curve for L-TRY in the presence of TCA.
Standard L-TRY solutions of 10, 20, 30, 40, 50 jig/ml were
prepared from which lOOpl samples were taken. The samples were
heated for 1 hour at 99° to 101°C with 0.2ml 1.8% formaldehyde
-4and 1.8ml 10% TCA containing 3 x 10 M FeCl^. After scanning 
Sjig norharman dissolved in 3ml O.IN hydrochloric acid (non­
incubated) and the Spg standard (Fig.11), the samples were 
read at excitation 290nm and 370nm and emission 450nm. Fig.12 
shows that relative fluorescence readings at excitation 290nm 
are greater than those at excitation 370nm. The standard curves 
are also linear in the presence of TCA unlike those in perchloric 
acid.
-4Expt. 3 The effect of 2.5 x 10 M FeCl^ (final concentration) 
on the relative fluorescence of norharman.
50pl of 10 FeClg or O.IN hydrochloric acid was added to 2mls 
of O.IN hydrochloric acid containing 0-50)il of solution of 
norharman. The samples were read at excitation 290nm and 370nm 
and emission 450nm. Fig.13 shows unreacted FeCl^ has a 
quenching effect on the standard curve of approximately 20%.
Expt. 4 The effect of increasing the volume of ultrafiltrate 
as a function of relative fluorescence.
The ultrafiltrate was prepared as described in section 3.2.2 (the 
brain was homogenised in 8mls of ice cold 0.9% saline) 0-500p,l 
samples of ultrafiltrate were made up to 1ml with distilled water 
heated at 99° to 101°C for 1 hour with 0.2ml 1.8% formaldehyde
73
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Figure 15 The relative fluorescence of TRY standards measured in the 
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Figure 16 The relative fluorescence of TRY standards measured in the 
presence of increasing amounts (50  ^ 100, 200 and 500]xl) of 
a protein -  precipitated brain extract.
Inset -  the relative fluorescence of TRY measure in brain 
extract samples: emission 450nm, activation 290nm
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-4and 1.8ml 10% TCA (w/v) containing 3 x 10 M FeCl^ and read at 
excitation 290nm and emission 450nm. Fig. 14 shows that 
the relative fluorescence was proportional to increasing sample 
volumes up to 300)il.
Expt. 5 Standard curve for L-TRY in the presence of the 
ultrafiltrate used to determine 'free' TRY.
10)j.l of the following standard TRY solutions:- 25, 50, 100,
200 and 400)ig/ml were added to 1ml of distilled water and 1ml 
of ultrafiltrate (for preparation refer to section 3.2.2).
100|il aliquots from each sample were made up to 1ml with 
distilled water and assayed as described in Expt. 4. Fig. 15 
shows that no interference occurs.
Expt. 6 Standard curve for L-TRY in the presence of increasing 
amounts of a TCA proetin-precipitated brain extract.
The brain extract was prepared as described in section 3.2.1. 
0-500;tfl extracts containing 25, 50, 100, 200 and 400ng of 
L-TRY were made up to 1ml with distilled water and assayed as 
described in Expt. 4. Fig. 16 shows the reduction in the 
relative fluorescence values for standards compared to a 
control curve as the volume of extract present in the mixture 
is increased although linearity is maintained. This 
experiment was then repeated using a 200p,l extract but with 
lOOng norharman added to each sample before heating. As seen 
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Figure 17 The relative fluorescence of TRY standards measured in the 
presence of a) 200\il protein-precipitated brain extract 
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Figure I S  The effect of increasing the volume of homogenisation medium 
on the concentration of 'free’ TRY in the rat brain. Total 
brain TRY estimations measured at each volume are expressed. 
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Figure 19 Data from the previous graph expressed on semi-log scale.
Extrapolation to the y axis represents the 'absolute free 
TRY concentration' in the rate brain. Concentration = 
y g /g r  wet brain weight
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the reduced fluorescence values for the standards prepared 
in the presence of brain extracts was not due to quenching 
of the final product.
Expt. 7 The determination of total, protein bound and 'free' 
TRY in the rat brain.
The assay was carried out as described in the method section 
3.2. Fig. 18 shows the effect of increasing the volume of 
homogenisation medium on the amount of 'free' TRY in the 
rat brain. This data can be re-plotted by changing the y 
axis to a log scale and retaining the x axis as a linear 
scale. The values now give a straight graph (Fig.19) which 
on extrapolation to the y axis gives a value of 3.20 |ig/g 
for the absolute concentration of 'free' TRY in the rat 
brain. Total TRY values are quoted on Fig. 18.
The 24-hour variation of total, bound and 'free' TRY in the 
rat brain
The assay was carried out as described in section 3.2.4.
The results are shown in Fig. 20 and Table 1. Having 
calculated a value for the 'absolute free' TRY concentration 
in the brain (Expt. 7), the results obtained for 'free'
TRY over 24 hours could thus be corrected to give 'absolute 
free' TRY values. As can be seen in Fig. 20 the circadian 
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Figure 20 The 24-hour variation of 'free' and total TRY concentrations in 
the rat brain
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Table 1 The 24-hour 
tryptophan
v a r ia t io n  o f to ta l ,  
in  the r a t  b ra in .
pgi/g
p ro te in  bound and ' fre e '
Clock Hour To ta l 'F ree ' 'Absolute Free' Bound
12.00 4.508 4.209 3.215 1.293
16.00 4.224 3.908 2.914 1.310
20.00 4.626 4.119 3.125 1.501
24.00 4.706 4.462 3.468 1.238
04.00 4.943 4.589 3.595 1.348
08.00 5.063 4.621 3.627 1.436
12.00 4.603 4.221 3.283 1.320
n = 10 fo r  each clock hour.
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3.4 Discussion
Hopkins and Cole (1903) first prepared harman from TRY. 
Unknown to them at the time, acetaldehyde, as a 
contaminant, had condensed with TRY and the side chain 
had subsequently cyclised in the presence of FeCl^ forming 
harman. Using the Pictet-Spengler reaction, Kermack et al.^ 
(1921) proved the correctness of the above sequence by 
synthesising norharman and harman with formaldehyde and 
acetaldehyde respectively. Hess and Udenfriend (1959) 
adapted this method for the measurement of tryptamine in 
tissues using hydrogen peroxide as the oxidising agent, 
no data however, was given as to the limits and optimal 
conditions of the method specifically applied to TRY 
determination. Denkla and Dewey (19 67) produced the same 
yield from TRY (40% in 40 minutes) as had been reported 
by the previous authors for tryptamine. To improve the 
method, they used FeCl^ as the oxidising agent instead of 
hydrogen peroxide and this increased the yield to 70% when 
heated at atmospheric pressure for 1 hour. Of the naturally 
occurring TRY derivatives tested, only tryptamine produced 
any appreciable fluorescence; one tenth of the molar 
fluorescence of TRY.
In this work, this simple, rapid and sensitive method was 
adapted to measure TRY in the brain. Perchloric acid could 
not be used as the denaturing agent in this assay because 
as seen from Fig. 10, it interferes with the assay so TCA
84
was used. Denkla and Dewey (1967) read their samples at 
excitation 370nm and emission 450nm. On scanning a 5jig 
sample of incubated tryptophan and 5jig non-incubated 
norhaman (in O.IN HCl), the emission peak occurred at 
450nm yet two excitation pecks were observed (Fig.11) 
at 290nm and 370nm, the former being greatest. The 
samples in this experiment were therefore read at excitation 
290nm and emission 370nm.
Denkla and Dewey (19 67) found that if norharman was added
to pre-incubated reagents or incubated with the reagents,
the fluorescence was 20% greater than if the former was
added to non-incubated reagents. This increase in
fluorescence appeared to be due to a change in the
constituents of the reaction mixture during incubation and
not to a change in the structure of norharman. Further
investigation showed that FeCl^ not formaldehyde or TCA
quenched the fluorescence in a non-incubated sample. A
decrease in FeCl^ concentration during incubation accounted
for the subsequent increase in fluorescence. Even after
incubating some residual quenching by FeCl^ remained.
Further studies with the quenching caused by FeCl^ revealed
that the quenching was concentration-dependant and that it
was completely reversed by dilution of FeCl^, with water to
a lower concentration. These observations were verified when
-4the effect of 2.5 x 10 M FeCl^ on the fluorescence of non-3
incubated norharman was investigated (Fig. 13). The
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standard curve for norharman was reduced by approximately 
20% when in the presence of FeCl^. Increasing the volume 
of ultrafiltrate used to determine 'free' TRY produced a 
linear increase in fluorescence up to 300)il (Fig. 14).
No interference was observed when TRY standards were 
measured in lOOjil ultrafiltrate samples (Fig. 15). This was 
not the case however when standards were determined in the 
presence of increasing volumes of denatured brain extracts.
As seen from Fig. 16 the recovery of TRY standards in 
50, 100 and 200 p,l extracts was 95%, 85% and 70% respectivelyj 
yet linearity was maintained. This effect was not due to 
quenching of the final product as lOOng norharman incubated 
with standards in 200 )il brain extracts gave the same 
fluorescence values as lOOng norharman samples incubated with 
reagents alone. 100 p.1 was selected for the routine assay 
since it gave an adequate recovery and was large enough to 
give accurate readings consistently.
The 'free' TRY measured in this experiment is defined as the 
non-protein bound fraction in the rat brain. The 
disadvantage of using a whole brain homogenate is that not 
only are levels in the neurons estimated but also those in 
glia and capillary vessels. There is no direct contact 
between neurons and their processes and the vascular system 
as the former are suspended within a sponge of neuroglial 
tissue (Glees,1973). Glial tissue must therefore have a 
metabolic transport function, as well as a supportive role.
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Also this 'free' TRY is not only available for amine
synthesis in serotonergic neurons but is a precursor for
melatonin in the pineal gland and for protein synthesis and
turnover. Since about 10% of brain weight is protein and
since each aromatic amino acid comprises about 5% of the
total amino-acid content of the protein, about 5mg of each
amino acid is incorporated into protein per gram of brain.
-4In contrast, the amines NA and 5-HT are only 10 as
abundant since they are found in concentrations of about 0.5
lig/g of brain. Even if one takes into account the more
 ^,
rapid turnover of amines./ The proteins remain the major 
product derived from aromatic amino acids in the brain.
Ideally, one would like to measure the amount of this 'free'
TRY which is available only to serotonergic neurons but this 
is not possible. As seen from Fig. 20 the circadian variation 
of 'free'TRY in the brain follows closely that for total TRY. 
This indicates that some other factor such as uptake of TRY 
into the neurons or the activity of the synthetic enzymes, 
tryptophan hydroxylase and/or 5-HTP decarboxylase could have 
a regulating function in order to explain the poor correlation 
between the circadian rhythm in brain TRY and 5-HT. Hery et al.^
3
(1972) showed an enhanced accumulation of { H } TRY in vivo 
in the light period during physiological or physical 
stimulation of 5-HT synthesis and suggested the implication 
of an active transport process to accelerate the transport 
of TRY into serotonergic neurons. The presence of a high 
affinity transport system was confirmed in synaptosomal
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preparations (Grahame-Smith & Parfitt 1970/ Knapp and 
Mandell,1972), it could be postulated that this system is 
a unique process of serotonergic neurons similar to the 
high affinity transport system of choline in cholinergic 
neurons (Kuhar et al.^ 1973). However, this is not the case 
as the systems studied have a wide specificity and also high 
affinity transport of TRY has been demonstrated in 
synaptosomal preparations free of serotonergic terminals 
(Kuhar et al.^ 1972) and in various cultured cells such as 
glial cells, fibroblasts and neuroblastoma clones (Bauman 
et al.^1974) . For these reasons it appears unlikely that 
synthesis of 5-HT is controlled by a step regulating the 
transport of TRY across the synaptosomal membrane and thus 
determining a crucial intracellular concentration of TRY 
in the vicinity of tryptophan hydroxylase.
I therefore decided to look at the activity of 5-HTP 
decarboxylase and tryptophan hydroxylase over 2 4 hours. 
Preliminary findings in our laboratories (Hillier and 
Redfern,1976) had indicated the possible existence of a 
circadian rhythm for 5-HTP decarboxylase so it was decided 
to investigate this more closely.
CHAPTER FOUR
The activity of 5-HTP decarboxylase 
measured over 2 4 hours
8 8
4.1 Introduction
The enzymatic synthesis of the biogenic amines 5-HT, DA and 
NA involves decarboxylation of the corresponding amino acids, 
5-HTP and DOPA. Dopa decarboxylase was the first enzyme in 
the catecholamine biosynthetic pathway to be discovered 
(Holtz et al., 1938). After the isolation and identification 
of 5-HT (Rapport et al., 1948; Rapport, 1949), Clark, Weissbach 
and Udenfriend (1954) found significant DOPA decarboxylase 
activity in their most highly purified preparations of 5-HTP 
decarboxylase from guinea-pig kidney. However the pH optima 
and cofactor requirements varied. In these early studies it 
was not possible to obtain separation of the two activities. 
Also the studies did not fully consider the fact that DOPA 
is a poor substrate to assay because it reacts with the 
coenzyme, pyridoxal phosphate to form a tetrahydroisoquinoline 
derivative (Schott and Clark, 1952) . Yuwiler, Geller and 
Eiduson (19 60) subsequently showed that there was competition 
between 5-HTP and DOPA for decarboxylation and that various 
inhibitors had similar actions on both decarboxylations.
Using an enzyme preparation purified 50-100 fold from guinea- 
pig kidney, Lovenberg et al., (1962) concluded that not only 
DOPA and 5-HTP were decarboxylated by the same enzyme but 
that the specificity of the enzyme was sufficiently broad to 
utilize all the naturally occurring aromatic amino acids 
including histidine and certain a methyl derivatives. They 
also showed competitive substrate inhibition and inhibition of 
all the activities by a methylamino acids. For these reasons, 
they proposed that the enzyme be named 'aromatic L-amino acid
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decarboxylase'. The close similarity in regional distribution 
of DOPA decarboxylase and 5-HTP decarboxylase activities in 
feline brain (Kuntzmann et al., 1961) provided experimental 
support for extrapolating the characteristics of the renal 
enzyme, particularly its broad substrate specificity, to the 
corresponding reactions in the brain. The possibility of 
more than one decarboxylase for aromatic amino acids in 
different organ systems was raised however when a partially 
purified DOPA decarboxylase preparation from liver was 
reported to exhibit significant differences in pH optima, 
substrate specificity and cofactor requirements from those 
of the kidney decarboxylase (Awapara et al., 1962) .
All the above investigations^ were limited because highly 
purified enzyme preparations were not available. Christenson 
et al., (1970) obtained preparations of hog kidney decarboxylase 
which were 99% pure as indicated by disc gel electrophoresis, 
sedimentation and immunological techniques. The purified 
enzyme had a molecular weight of 112,000 daltons and was 
associated with tightly bound pyridoxal-5-phosphate (P5P).
The enzyme decarboxylated DOPA, 5-HTP, TRY, phenylalanine and 
tyrosine at readily measurable rates. Slow decarboxylation 
of histidine also occurred. A subsequent report (Christenson 
et al., 1971) showed that the anti-serum to this purified 
hog kidney enzyme also reacted with preparations from other 
tissues and other species suggesting that the same enzyme or 
a close homologue was widely distributed. Anti-serum titrations 
have shown that both DOPA and 5-HTP decarboxylase activities 
were lost at the same rate (Christenson et al., 1972) again
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suggesting that a single enzyme is responsible for both 
activities. Further evidence to support the findings that 
the enzyme has the ability to utilise both DOPA and 5-HTP 
was shown when large loading doses of 5-HTP increased 
indoleamine fluorescence in catecholamine containing neurons 
as well as serotonergic neurons (Butcher et al., 1972). In 
contrast, loading doses of L-DOPA increased catecholamine 
fluorescence in both serotonergic and dopaminergic neurons 
(Butcher et al., 1970) .
This evidence must be reconciled however with the observations 
of Sims and Bloom (1971) , who undertook a detailed study of 
DOPA decarboxylase and 5-HTP decarboxylase to establish assay 
characteristics and distribution in the rat brain by using a 
sensitive microradiometric technique. The two activities 
exhibited widely different optima for pH, temperature and 
substrate concentrations. The activity of 5-HTP decarboxylase 
was stimulated 2-fold by added P5P and was relatively resistant 
to antagonists of the latter. By contrast, the activity of 
DOPA decarboxylase was stimulated 20-fold by added coenzyme 
and could be completely inhibited by carboxyl-trapping 
agents. Dopa decarboxylase activity in subcellular fractions 
of brain was associated predominently with the soluble 
fractions and its distribution in the various fractions 
closely paralled that of lactic acid dehydrogenase. These 
results are in agreement with previous subcellular fraction­
ation studies on renal and cerebral DOPA decarboxylases 
(Laduran and Belpaire, 1968; McGear et al., 1965). A
01
cytoplasmic location for DOPA decarboxylase is also consistent 
with the localisation of its product DA (Laverty et a l 1963) 
in supernatant fractions. 5-HTP decarboxylase activity in 
brain was distributed almost equally between soluble and 
particulate fractions and its distribution within the 
particulate fractions differed from that of succinic acid 
dehydrogenase. These findings agree with earlier experiments 
on the subcellular localisation of cerebral 5-HTP decarboxylase 
activity (Rodriguez De Lores Arnaiz and DeRobertis, 1964). 
Similarly, the regional distributions of the two decarboxylases 
in rat brain did not parallel one another. Rostal areas 
exhibited the highest DOPA decarboxylase activity e.g. the 
activity in the corpus striatum was 11-fold greater than in 
the whole cerebellum. The activity of 5-HTP decarboxylase 
relative to that of DOPA decarboxylase was greater in hindbrain 
regions (medulla-pons and cerebellum), although its maximal 
activity per unit weight was in the telencephalon. It was 
suggested that the enzymes might be so closely related 
structurally as to be identical by the immunological criteria 
used by Christenson et al., (1972).
,
Bender and Coulson (1972) had also found that electrophoretic 
studies on rat liver DOPA and 5-HTP decarboxylase consistently 
failed to show any separation of the two activities under a 
variety of conditions indicating that a single protein is 
responsible for both activities (Coulson et al., 1969; Bender 
and Coulson, 19 73). Yet they demonstrated that the two enzymes 
have different pH optima for decarboxylation (DOPA at pH 
6.6 - 7.0 and 5-HTP pH 7.8 - 8.0) but are mutually competitive.
02
They also showed that the ratio of activity of the liver 
enzyme towards the two substrates could be altered by mild 
treatments, such as might be used in solubilization of brain 
preparations. Dopa decarboxylase activity was preferentically 
inactivated by sodium dodecyl sulphate treatment and 5-HTP 
decarboxylase by urea. Inhibition of DOPA decarboxylase by 
the detergent also relieved the inhibition of 5-HTP 
decarboxylation by DOPA and the corresponding observation 
applied for DOPA decarboxylation inhibited by 5-HTP. In an 
attempt to explain their results. Bender and Coulson (1972) 
proposed that since there was only one molecule of P5P per 
molecule of enzyme (Christenson et al., 1970) it must be 
assumed that there can only be a single catalytic site on the 
molecule but the difference in pH optima for the two substrates 
might reflect two separate affinity sites which could be 
differentially inactivated. This could explain the 
observations of Sims and Bloom (19 71) on the brain enzyme, 
which being partially membrane bound or enclosed could be 
modified by the extraction techniques. Differences in the 
ionization of the affinity sites might then determine the 
pH optima towards the substrates and the differential effects 
of sodium dodecyl sulphate and urea could be explained by 
differential sensitivities of the two sites.
The existence of a single enzyme catalyzing the same type of 
reaction in different biosynthetic pathways is an unusual 
circumstance in mammalian biochemistry. The situation 
concerning brain tissue has not been clarified fully and I
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believe the practise of using 5-HTP or DOPA interchangeably 
as substrates to assay 'aromatic L-amino acid decarboxylase' 
may provide misleading information in studies utilising brain 
hompgenates. For this reason, 5-HTP has been used as the 
substrate to measure the activity of 5-HTP decarboxylase 
over 24 hours in this thesis.
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Fig. 21 Mechanism of action of the co-factor pyridoxal-
5-phosphate in the decarboxylation of 5-HTP.
The aamino group of 5-HTP reacts reversibly with the 
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Male CFY rats (l80-220g) were killed by decapitation, the 
brains dissected out and the pineal glands discarded. After 
weighing, each brain was homogenised in 8ml of ice-cold 
0.32m  sucrose using a teflon pestle and a glass tube 
homogeniser with a 0.01" radial clearance and revolving at 
800 rpm. The homogenates were centrifuged at lOOOg for 10 
mins at 4^C, the supernatants collected and diluted 
(Ivol + 3vols 0.32M sucrose) and 1ml of this preparation was
made up to 2.2ml to form the final incubation mixture. This
-5 -5contained 0.45 x 10 M pargyline and 1.82 x 10 M P5P adjusted
to pH 8.0 with phosphate buffer. Fig. 21 shows the mechanism
of action of P5P in the decarboxylation of 5-HTP. The mixture
was pre-incubated at 37^C for 10 mins before the addition of 
-51.25 X lO M DL-5-HTP*. The incubation was allowed to proceed 
for 15 mins and was stopped with 0.1ml 4N sulphuric acid. The 
mixture was centrifuged at lOOOg for 10 mins to remove 
precipitated proteins.
4.2.2 Extraction
The 5-HT contained in the resulting supernatant was extracted 
and assayed by adapting the method described by Snyder et al., 
(1965) .
*These were the optimal conditions under which the enzyme 
activity was measured. DL-5-HTP substrate concentrations 
sometimes varied however depending on the experiment 
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Figure 24 The relative fluorescence of 5-HT measured before and after 
organio extraction: emission 490nm, activation 385nm
Cï 0
Each supernatant was added to 2ml 0.5M borate buffer 
(pHlO, saturated with NaCl and washed n-butanol). The pH 
was adjusted to pH 10 with 5N NaOH and this solution added 
to 20ml of washed n-butanol and 2g NaCl in a 125ml 'medical 
flat' bottle, which was shaken for 5 min and centrifuged 
at l,000g for 5 min. The aqueous layer was discarded and 
another 2ml of borate buffer and 2g NaCl were added. The 
contents of the bottle were shaken and centrifuged at l,000g 
for 5 min. 15ml of the n-butanol phase was transferred to 
another bottle containing 20ml n-heptane and 2ml of 0.05M 
phosphate buffer (pH7). This was shaken and centrifuged at 
l,000g for 10 min. 1.2ml of the aqueous layer was added to 
0.1ml of O.IM ninhydrin, heated for 25 min at 100°C and 
allowed to cool for 1 hour. The fluorescence was read in an 
Aminco Bowman spectrophotof luorimeter at activation 385nm, 
emission 490nm. Internal standards (500ng 5-HT) were added 
to the supernatant from the incubation, external standards 
(500ng 5-HT) were prepared in 0.32M sucrose and extracted as 
described. Figs. 22 and 23 illustrate a summary of the 
incubation and extraction methods.
4.3 Results
Expt. 1 A comparison of the fluorescence intensity of the 
ninhydrin derivative of standard and extracted 5-HT.
A curve of the relative fluorescence of extracted 5-HT 
standards over the range 50-1000ng was constructed and 
compared to that obtained for non-extracted standards covering 
the same range. Fig. 24 shows the fluorescent values produced
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igure 26 The effect of altering P5P concentration on 5-HTP decarboxylase activity
Velocity expressed as \imoles 5-HT formed g wet brain weight/hour.
o *5Conditions of incubation - pH8^ 37 C, 15 min; pargyline 0.45 x 10
-5
DL 5-HTP 1.25 X 10 M (final concentrations)
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Figure 27 The effect of increasing incubation time on 5-HTP decarboxylase 
activity at the highest and lowest concentrations of 5-HTP used 
for the kinetic studies.
Velocity expressed as \imoles 5-HT formed/g wet brain weight/hour
Conditions of incubation -  pH8, 15 min;
-5 -5pargyline 0.45 x 10 P5P ^.82 x ^0 M (final concentrations)
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a linear graph in both cases over the range chosen and the 
calculated recovery estimated as 56 + 1.1%. Fig. 25 shows 
a fluorescence spectra of the ninhydrin derivatives of a 
standard and extracted 5-HT sample.
Expt. 2 The effect of altering P5P concentration on 5-HTP 
decarboxylase activity.
The effect of P5P on enzyme activity was assessed using
preparations from rats killed at 05.00 and 17.50 hours. As
seen in Fig. 26 the velocity of the reaction increased with
increasing P5P concentrations until a maximum velocity was
-5attained at 0.45 x 10 M P5P (final concentration). This 
effect was seen at both clock hours measured.
Expt. 3 The effect of increasing incubation time on enzyme 
activity at the highest and lowest substrate concentrations 
used for the kinetic studies.
Fig. 27 shows that at substrate concentrations of 10 ^ a n d  
-5ID M the velocity of the reaction is linear over the time 
ccurse measured.
E{pt. 4 The estimation of Vmax and Km for 5-HTP decarboxylase 
a: 17.00 and 05.00 hours.
Tie method used was that described in section 4.2 except a
-5 -5
range of DL-5-HTP concentrations :- 10 M, 1.25 x 10 M,
— 5 — 5 — 42 X 10 M, 4 X 10 M, 10 M (final concentrations) was used.
Tie results were plotted as velocity against substrate (Fig.28)
10 i
velocity
jjmolesygy^hr m. 43 dark period ^ 0 5 * 0 0  hrs)
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Figure 28 The activity of 5-HTP decarboxylase as a function of substrate 
concentration.
Velocity expressed as \imoles 5-HT formed/g wet brain weight/hour
Conditions of incubation - pH8, 37^0, 15 min;
-5 -5pargyline 0.45 x ^0 M, P5P . 8 2 x ^ 0  M (final concentrations)
Fig. 29 Data from the previous graph expressed in the form o; 
a Lineweaver - Burk plot.
V = velocity (jimoles 5-HT formed/g wet brain weight/ 
hour.
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Figure 30 The 24 hour variation in 5-HTP decarboxylase activity in the 
rat brain.
Velocity expressed as \imoles 5-HT formed/g wet brain weight/hour
Conditions of incubation - pH8, 37^0, 15 min;
-5 -5
pargyline 0.45 x ^0 M, P5P '1.82 x 'lO Mf
-5DL 5-HTP 5 X 10 M (final concentrations) 
n = '[O at each clock hour
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and the reciprocal values used to construct a Linev/eaver- 
Burk graph (Fig. 29). The Vmax and Km values for the two 
clock hours were as follows :-
Clock hour Vmax Km
(dark) 05.00 0 .510 jimol g ^hr  ^ 1.39 x 10
(light) 17.00 0 .465 jimol g ^hr  ^ 1.28 x 10
The activity of 5-HTP decarboxylase estimated over 24 hours.
In this experiment, the enzyme activity was measured at 4
hourly intervals over 24 hours and at one substrate
-5concentration only 5 x 10 M (final concentration)as seen in
Fig. 30, although a small variation in activity occurred
between values estimated at 0 5.00 and 17.00 hours, the peak
activity was reached at 09.00. The observed data were
analysed by fitting the results to a sine curve, a geometric
model with a natural, recognised rhythm. It is assumed that
if the data do not significantly differ from the calculated
sine curve, then a rhythm is in evidence, whose highest values
do differ from the lowest values. The best fit sine curve
has been calculated using the Fourier analysis and the
experimental data compared to the calculated data by means 
2
of the X test. The results were significantly different from
the calculated sine curve indicating that no circadian 
variation existed.
4.4 Discussion
Following the observations of Jepson and Stevens (1953) that 
5-HT developed strong fluorescent properties after exposure to 
ninhydrin and heat, Vanable (1963) developed a quantitative
0 8
-1 -1
Clock hour pmol h r g wet b ra in  w t.
01.00 0.398 + 0.012
05.00 0.414 + 0.010
09.00 0.419 + 0.015
13.00 0.401 + 0.012
17.00 0.400 + 0.010
21.00 0.398 + 0.014
Table 2 24-hour v a r ia t io n  in  5-HTP decarboxylase a c t iv i t y  
in  the ra t  b ra in .
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fluorescence assay for 5-HT using standard solutions. The 
fluorescence was eight times more intense than the native 
fluorescence of 5-HT in strong acid solution. This technique 
was later applied to tissue samples and the specificity of 
the reaction was determined by Snyder et al., (1965) . The 
peak fluorescence of the 5-HT ninhydrin product is achieved at 
pH 6.5, therefore 5-HT can be extracted into phosphate buffer 
and the ninhydrin reaction performed directly. It is necessary 
to leave the reacted samples for 1 hour as the fluorescence 
of the product increases approximately 10% during the first 
20 minutes following incubation and then remains stable for 
6 hours. A linear range of relative fluorescence occurs over
0.005 - 0.5 jig 5-HT/ml. A wide variety of related hydroxyindole 
and catechol compounds react with ninhydrin but only bufotenin 
and 5-HTP were reported to yield an appreciable amount of 
fluorescence (2% and 1% respectively).
In these expereiments the recovery of extracted 5-HT formed
during incubation was 56 + 1.1%. For the kinetic studies the 
"•5 “"4range of 10 M to 10 M DL-5-HTP was chosen and the velocity 
of the reaction at these two substrate concentrations was 
measured over 20 mins to ensure linearity (Fig. 27). Most 
reaction curves are straight lines up to approximately 20% of 
the reaction and as long as measurements are made in this 
linear range, the rate of substrate utilisation is a true 
measure of enzyme activity.
Preliminary findings from our laboratories (Hillier and
1 1 0
R e d f e m , 1976) had indicated a circadian rhythm in 5-HTP
decarboxylase the peak value occuring at 17.00 hour (i.e.
11th hour of dark), thus for the kinetic studies, this was
the clock hour chosen at which the enzyme activity was
measured as well as at 05.00 hour (i.e. 12 hour later).
Initially, the effect of increasing P5P concentrations was
measured at these two clock hours to establish whether the
added cofactor was affecting activity differently. As seen
from Fig. 26 this was not the case and activity increased to
-5a maximum at a P5P concentration of 0.45 x 10 M a t  both 
clock hours.
The experimental data from the kinetic studies were displayed 
in the traditional form of Lineweaver-Burk plots for the two 
clock hours and were analysed statistically by fitting 
rectangular hyperbolae using a maximum likelihood computer 
program (MLP, Ross et al.,). The difference between the 
two lines was small but the values at 17.00 hour were always 
greater than 05.00 hour. The statistical analysis showed a 
highly significant separation between the lines but no 
significant difference between their slopes. However, when 
the activity of the enzyme was measured over 24 hours, (Fig. 
30) although a difference still existed between 17.00 and 
05.00 hours, no statistically significant circadian variation 
was observed.
It is difficult to explain the functional significance of 
this observed difference for the rate of 5-HT synthesis at 2
: I i
clock hours when apparently >no 24-hour variation exists.
Also the latter does not substantiate the preliminary findings 
in our laboratories. This could be explained possibly by 
animal strain differences (the Sprague-Dawley strain compared 
to CFY) or method differences. In this experiment a 
fluorimetric method was used which could be considered less 
sensitive than as isotopic method used originally. However, 
the isotopic method required a far lengthier extraction 
procedure to separate the radioactive substrate from product 
causing a low recovery and a blank value which was still 
high. With the fluorimetric method, the extraction procedure 
was more simple as any increased 5-HTP present in the final 
solution to be heated with ninhydrin did not interfer 
because it yielded negligible amounts of fluorescence. Thus 
recovery values were high and blank values low. Any increase 
in the degree of sensitivity gained from using an isotopic 
method was lost due to the extraction procedure necessary.
In attempting to explain the difference, perhaps the most 
relevant findings from earlier work were that when a purified 
enzyme extract was used, prepared by the method of.Clark et al., 
(1954), no 24-hour variation was seen. Therefore, it was 
concluded that in the crude extract, the variation in the 
activity of the enzyme was due to other factors. There was 
no variation due to endogenous or exogenous P5P. Equally the 
availably of the precursor, did not appear to affect the 
activity of the enzyme since pretreatment with PCPA at 
different clock hours did not significantly alter the rates
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of synthesis. It was suggested that as 5-HTP decaboxylase 
has the ability to utilize DOPA as a substrate perhaps 
competition between 5-HTP and DOPA could be a controlling 
factor.
Possibly, method and animal variation mask what could be 
consistently small fluctuations in enzyme activity or maybe 
the importance of endogenous 5-HTP levels should be considered 
5-HTP levels in the rat brain are low (Linguist et al., 1975), 
because the maximum velocity of tryptophan hydroxylase, the 
enzyme which converts TRY to 5-HTP is lower than that of 
5-HTP decarboxylase (Ichiyama et al., 1968), so the former 
step is thought to be rate-limiting. For this reason, it 
seemed logical to investigate the activity of this enzyme to 
see how it affected levels of 5-HTP, the latter then serving 
as the substrate for 5-HTP decarboxylase. The synthetic 
pathway for 5-HT in terms of enzyme activity could then be 
assessed as an integated unit.
CHAPTER FIVE
The activity of TRY hydroxylase 
measured over 24 hours
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5.1 Introduction
The first evidence of a specific TRY hydroxylase enzyme 
in normal mammalian tissue was reported by Grahame-Smith 
(1964). The enzyme was detected in homogenates of whole 
brain from dogs and rabbits but not in the high speed 
supernatant fraction from the centrifugate of the brain stem. 
Subsequent reports from several laboratories have also 
described the hydroxylation of TRY in vitro with extracts 
from various mammalian brain tissues (Gal, 1965j Gal et al., 
1966; Nakamura et al., 1965; Lovenberg et al., 1967;
Jequier et al., 1967; Grahame-Smith, 1967). This enzyme 
activity was also observed in intact cells of chromo­
bacterium violaceum (Mitoma et al., 1956), cell free 
extracts of carotinoid tumors (Lovenberg et al., 1967) and 
mouse neoplastic mast cells (Levine et al., 1964; Lovenberg, 
et al., 1965).
The biosynthesis of the putative neurotransmitter, 5-HT 
involves two consecutive reactions, the first being the 
hydroxylation of TRY to form 5-HTP, which is catalysed 
by TRY hydroxylase. The 5-HTP is then decarboxylated to 
5-HT (Udenfriend et al., 1957). It is believed (though 
largely untested) that TRY hydroxylation may function as 
a rate-limiting step in 5-HT formation, because its 
maximum velocity is lower than that of the 5-HTP 
decarboxylase which controls the successive step (Ichiyama 
et al., 1968) . This is supported by the fact that endogenous 
levels of 5-HTP in the brain are very low (5-25 ng/g) 




The anatomical distribution of TRY hydroxylase closely 
parallels the content of 5-HT in the rat brain (Saavedra,
19 77). The enzyme is especially concentrated in the 
raphe nuclei, which contain large numbers of serotonergic 
cell bodies. The highest concentration among the raphe 
nuclei and also the highest for cells in the brain areas 
studied was found in the nucleus raphe dorsalis. There 
was a 43 fold difference between the concentration there 
and the lowest level measured which was in the cerebellar 
cortex. TRY hydroxylase is also concentrated in regions 
of the brain through which dense bundles of serotonergic 
axon terminals travel. Notable among these is the median 
forebrain bundle in the posterior hypothalamus. In the 
limbic system there are relatively high levels in specific 
areas such as the cingulate cortex, the nucleus tractus
n
diagonalis, the nucleus septalis medialis and the nucleus 
amygdaloideus lateralis. In the mesencephalon, tlie nucleus
h
interpeduscularis, the area tegmentalis ventralis, the 
colliculus superior and substantia grisea centralis are 
the areas with highest activities. Other brain areas 
with moderate enzyme activity are the locus coeruleus, 
the inferior olive, and the area postrema. In the 
pituitary gland, TRY hydroxylase activities are higher in 
the intermediate and posterior lobes.
-p -«
5.1.2 Co-factor requirements
Early work with TRY hydroxylase in vitro (Jequier et al., 
1967) showed that the Km for TRY using a synthetic 
cofactor 6, 7 dimethyl-tetrahydropterin (DMPH^) was 
300jiM. This value is far above the plasma or brain 
concentration of TRY both of which are approximately 
30jj,M for rats (Grahame-Smith, 1971; Fernstrom and Wurtman, 
1971). This generated considerable speculative interest 
that the enzyme might not normally be saturated and 
that the overall rate of 5-HT synthesis might be partially 
dependent on the availability of TRY. Subsequent work 
however (Friedman et al., 1972) showed that the Km for 
the enzyme varied significantly with the pterin cofactor 
used. The value in the presence of the naturally occurring 
cofactor tetrahydrobiopterin (BH^) was 50)iM which is more 
consistent with in vivo observations using TRY loading 
(Fernstrom and Wurtman, 19 71) than the previously accepted 
value of 300)iM. A dose of 50 mg/kg TRY intraperitoneally 
caused the brain TRY concentration to increase approximately 
three-fold (90^M) and the 5-HT concentration to double 
but further increases of brain TRY (up to 270|iM) did not 
produce appreciable increases in the amount of 5-HT. 
Grahame-Smith (1971) noted a similar effect but found that 
the maximum rise in 5-HT occurred with a dose of 120 mg/kg 
TRY which produced a brain TRY concentration of 
approximately 350jiM. Thus, 5-HT formation in vivo is 
maximal when the brain TRY concentration rises by 3-6 
times (reaching 3-6 times the Km of TRY hydroxylase 
measured in vitro with BH^ as the cofactor). A similar
conclusion was derived from estimates of the in vivo
activity of TRY hydroxylase (Carlsson et al., 1973b).
This method involves the inhibition of 5-HTP decarboxy­
lase with, for example, 3-hydroxybenzylhydrazine (NSD 1015) 
5-HTP accumulates in the rat or mouse brain initially 
at a constant rate. Efflux is slow so accumulation 
of this intermediate essentially reflects its rate of 
formation and should serve as an indicator of the in vivo 
activity of the hydroxylase. It was found that TRY 
hydroxylase was slightly less than half-saturated with 
its amino acid substrate. The TRY content of the brain 
had to be increased by several times its normal level 
before the maximum rate of hydroxylation was observed.
The Km calculated was 60p.M. Inhibition by high 
concentrations of TRY was not observed. Thus, it appears 
that TRY hydroxylase is not saturated in vivo and that by
changing the brain TRY concentrations it is possible to
control the rates of 5-HT synthesis and accumulation.
5.1.3 Stoichiometry of the reaction
Friedman et al., (1972) showed that with tetrahydropterin 
(BH^) 1 mole of 5-HTP was formed for each mole of BH^ 
oxidised. This result, taken together with their 
demonstration that hydroxylation is stimulated by 
dihydropteridine reductase led to the reaction being 
formulated as in the diagram below:-
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They also showed that the pterin functioned as a cofactor
i.e. it functioned catalytically during hydroxylation.
The pterin cofactor can only function in the reduced form 
and dihydropteridine reductase, which has been isolated 
and purified from liver homogenate (Craine et al., 19 72) 
can maintain the cofactor in this state. The enzyme is 
also present in high concentrations in liver, kidney, 
brain and adrenal medulla. This reductase might be 
regulatory for the hydroxylation of TRY (Musacchio et al., 
1971) but such a possibility is not substantiated by the 
available data (Craine et al., 1972). It would seem that 
the amount of reduced BH^ rather than the reductase could 
perform a regulatory function. The concentration of 
BH^ in the brain is estimated to be 0.75 mg/g (3p,M if 
evenly distributed; Guroff et al., 19 67) , but inferences 
as to the regulatory potential for the biosynthesis of 
5-HT in brain are premature until more is known about 
the regional and cellular distribution of BH^.
i . M
Cofactor requirements vary according to whether a
synaptosomal or soluble enzyme preparation is used. With
a synaptosomal preparation DMPH^, NADHg, ascorbic
acid, Fe^ "*" ions or sulphydryl compounds e.g.
3-mercaptoethanol or dithiothreitol did not stimulate
the hydroxylase activity significantly (Ichiyama et al.,
1970; Friedman et al., 1972). Presumably the reductant
in this system is generated in situ by some endogenous
substance which is unknown at present. The enzyme
activity in the supernatant fraction showed an absolute
requirement for BH^ and was stimulated by reduced
pyridine nucleotide, dihydropteridine reductase, a high
concentration of 3-mercaptoethanol or dithiothreitol and
catalase. NADPH could substitute at least in part for
the sulphydryl reagent but not the reduced pteridine.
2 +Fe ions also stimulated the reaction but only in the
absence of catalase; this finding suggests that catalase 
2 +or Fe protects a sensitive component of the TRY 
hydroxylase system from inactivation of hydrogen peroxide 
(Friedman et al., 1972). Ichiyama et al., (1970)
measured the Km for the different preparations and found 
the Km for the soluble TRY hydroxylase to be approximately 
lOG|iM while that for the synaptosomal enzyme was 
approximately 20^M. This led to the suggestion that two 
different TRY hydroxylases, characterised by different 
Km values for TRY may be present in the brain. These 
two values are close to those observed by Friedman et al., 
(1972) for TRY in the presence of DMPH^ and BH^ respectively
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In the first experiment the soluble enzyme was assayed 
in the presence of DMPH^ and the synaptosomal preparation 
in the presence of endogenous cofactor. Since the brain 
pterin cofactor is probably identical with, or closely 
related to perhaps the differences in Km values are
not characteristic of a soluble and particulate enzyme 
but are characteristic of the pterin cofactor by which 
the hydroxylase is functioning (Friedman et al., 1972) .
The Km for oxygen is also strongly influenced by the 
pterin cofactor used. In the presence of BH^ the Km 
was found to be 2.5% which is less than the oxygen 
concentration of 5% in the brain of animals breathing 
air (Jamieson and Van den Brenk, 1965). It seems likely 
therefore that the enzyme is not normally limited by 
oxygen supply. This conclusion contrasts greatly with 
the one that would have been reached if the Km for oxygen 
of 20%, determined in the presence of the artificial 
cofactor DMPH^, was relied on (Friedman et al., 1972).
The sensitivity to inhibition by high concentrations of 
TRY is apparent with BH^ as cofactor but not with ’
DMPH^ (up to 2 mM TRY).
5.2 Method
The method is an adaptation of that described by Ichiyama 
et al., (1970). It involves no separations and utilizes 
the differing affinity of 5-HTP decarboxylase for two 
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3 to 14 mM), so that in a mixture of TRY and 5-HTP at 
low concentrations, the latter compound will be 
decarboxylated preferentially.
5.2.1 Preparation of the synaptosomal sample
Male CFY rats (l80-220g) were stunned and decapitated.
The brains were rapidly removed and the pineal gland 
discarded. Following weighing, the brains were homogenised 
in ice-cold 0.32M sucrose using a teflon pestle and glass 
tu&e homogeniser with 0.01" radial clearance to form a 
10% homogenate. The latter was centrifuged at 1^000 x g 
for 10 mins at 4°C. The resulting supernatant was 
decanted off and centrifuged at 12,000 x g for 20 mins.
1 2 1
Homogenise whole rat brain (excluding 
pineal) in 0.32M sucrose to produce a 
10% homogenate









Resuspend in 1Gml 0.32M sucrose 
Take 1ml of this solution and 
make up to 15ml with 0.3214 sucrose 
Use 1.5ml of this enzyme 
preparation for the incubation





- P  - P C -H 
•H -P
I—I
> 5  O
% 0)c Cm
•H Cm C
pi OO rC, •H X— c -1—1 -P 03f—1 <D Cd A Lû
O -P A OCm Cd cd -H +O -p A  -P
0)0 <D 03 03 CdrC r~ O 03 A Ph cri >H 03
-p Cd o A  -P Eh Cri rHp C 1 Eh -P
0) -p 03 o 03 03 Al 1 -P
-p  cd •H p S ü hP O
cd U 03 ^  H rH O fi^  C Eh N O OP -H (—i C O E ^ 03
O e 1—( O 0) A Aiü o O A LA O -P















1 2  3
The pellet formed was resuspended in 10 ml 0.32 M 
sucrose; 1ml of which was made up to 15 ml with 0.32M 
sucrose (i.e. 150 dilution of the original pellet).
This synaptosomal preparation was used for the enzyme 
assay. A summary of this method is shown in Fig. 31.
5.2.2 Incubation
Tris acetate buffer pHS.l (500)imol) and 1.25 mmol
sucrose were pre-incubated with 1.5 ml of the enzyme
preparation in a 15 ml narrow neck bottle (Fig. 32)
for 10 mins at 37^C. 25 nmol L-TRY + 6.7 nmol DL-
14{carboxyl - C} TRY (4 44,000dpm) was injected into the
reaction mixture whose final volume was 5 mis. The
-6final concentration of L-TRY was 5.67 x 10 M. A micro
test-tube was placed inside the bottle and the latter
was clamp sealed. The reaction proceeded for 30 mins
and was terminated by the injection of 1 ml 4N HCIO^
into the bottle. The acid also serves to release the 
14CO^ produced from solution,0.5 ml of O.IM hyamine
hydroxide (diluted with n-butanol) was injected into the
micro test-tube and the incubation was.continued for a
further three hours to allow complete absorption of the 
14released CO^ by the hyamine. Hyamine is a high-
molecular weight quaternary amine. Passman et al.,
(1956) were the first to use this substance for collecting 
14COg. It is toxic towards most biological systems which 
is why it is necessary to add the organic base at the end 
of the incubation period.
Fig. 33 The effect of varying the enzyme concentration on
hydroxylase activity at a final L-TRY concentration 
of 1.067 X 10-5M.
37.5ml, 75ml, 150ml dilution of P2 pellet with 0.32M 
sucrose.
Conditions of incubation - pH8, 37^C, 0-60 min; 
500)j.mol Tris acetate buffer, 1.25 mmol sucrose,
1.5ml enzyme prep^ 50nmol L-TRY + 6.7nmol DL^ C-TRY 
(final concis) in total vol. of 5ml.
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Fig. 34 The e f fe c t  o f varying the enzyme concentration on hydroxylase 
a c t iv i t y  at a f in a l  L-TRY concentration o f 1.007 10 ^M.
37.5ml, 75ml, 150ml d i lu t io n  o f Pg p e l le t  w ith 0.32M sucrose. 
Conditions o f incubation - pH8, 37°C, 0-60 min; 500umol Tris  
acetate b u ffe r ,  1.25mmol sucrose, 1.5ml enzyme prep^, 50nmol 
L-TRY + 6.7nmol DL^^C-TRY ( f in a l  concis) in  to ta l  vo l. 5ml. 
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Fig. 35 The effect of varying the substrate concentration on 
TRY hydroxylase activity.
Conditions of incubation - pH8, 37°C, 0-60 min;
500)j.mol Tris acetate buffer, 1.25 mmol sucrose, 1.5 ml 
of xl50 dilution of enzyme prep^, L-TRY 5.067 x lO^^M, 
1.067 X 10”5m, 5.67 x lO^^N (final concis) in total vol 
of 5ml.
Velocity expressed as nmoles 5-HT produced/g wet brain 
weight/hour.
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Fig. 36 The effect of altering the substrate concentration
(1 .0 67 X 5.67 x 10*"^M L-TRY) on TRY hydroxylase
activity.
Conditions of incubation - refer to Fig. 35.
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The seal was removed from the bottle and an aliquot of 
hyamine transferred to a vial containing 10 ml of 
Triton-xylene scintillant for counting. Blanks were 
prepared by injection of the acid into the bottle before 
addition of the substrate.
This assay procedure was used to determine the activity 
of TRY hydroxylase over 24 hours. In the results section 
the way in which variables within the method were 
altered to achieve these optimal conditions is described 
and experiments were also carried out to assess the 
sensitivity of the method.
5.3 Results
Expt. 1 The effect of varying the enzyme concentration. 
Three dilutions of the original pellet were used (37.5 ml, 
75 ml, 150 ml) and two final substrate concentrations 
(1.067 X 10 and 1.007 x 10 L-TRY). The incubation 
was carried out for 5, 10, 20, 40 and 60 min. The results 
(Figs. 33 and 34) show that at the dilutions and 
concentrations used the formation of 5-HT did not proceed 
at a constant rate nor did it double as the pellet 
dilution halved.
Expt. 2 The effect of varying the substrate concentration.
Using the 150 ml pellet dilution and the following final
concentrations of L-TRY:- 5.67 x 10 ^M, 1.067 x 10 
-5and 5.67 x 10 M, the enzyme activity was measured over 
60 mins. The results (Figs. 35 and 36) show that only
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Table 3
In h ib it io n  o f tryptophan hydroxylase by p-ch lo rophenyla lan ine .
4 exp. ra ts  -  400 mg/kg PCPA 24 hours p r io r  to  s a c r if ic e
4 co n tro l ra ts  -  sa line
X 150 p e l le t  d i lu t io n  5.67 x 10 L-TRY 
Incubated 37°C fo r  30 mins a t pH 8.1











The experimental animals showed a 39.74% reduction in  tryptophan 
hydroxylase a c t iv i t y .
: 3 0
at 5.67 X 10”^M did 5-HT formation achieve a constant 
rate and be half that obtained at x2 the substrate 
concentration. This pellet dilution and substrate 
concentration were chosen for the final experiment.
Expt. 3 Estimation of the Km and %iax for TRY hydroxylase. 
A rough estimate of the Km and %iax values of the 
enzyme were calculated by using substrate and velocity 
values obtained from experiments 1 and 2 and constructing 
a Lineweaver-Burk plot. The Km was calculated as 61.5^M 
and \^ax 125 nmol/g/hr.
Expt. 4 Inhibition of TRY hydroxylase by 
p-chlorophenylalanine (PCPA).
This experiment was carried out to verify the fact that 
the method was measuring the activity of TRY hydroxylase 
and not an artefact. Experimental rats were injected 
intraperitoneally with 400 mg/kg PCPA (100 mg/ml PCPA 
hydrochloride buffered to pH5.5 with 0.5N Na OH) 24 hours 
prior to sacrifice. Control rats were injected with 0.9% 
saline. As the results show (Table 3),. there was an 
approximately 40% reduction in TRY hydroxylase activity 
in the experimental rats.
Expt. 5 The effect of varying the specific activity of the 
substrate.
A 150 ml pellet dilution was used and the final substrate 
concentration (L-TRY) was 5.34 x 10 ^M. The following
Fig. 37 The effect of altering the specific activity of the 
substrate on TRY hydroxylase activity.
Conditions of incubation - pH8, 37°C, 30 min;
500)imol Tris acetate buffer 1.25 mmol sucrose,
1.5ml of X 150 dilution of enzyme prep^ altered ^^C 
DL-TRY conc^ (0.025 p,ci— >0,4 )j,ci) within total L-TRY 
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Comparison o f acid to  heat in a c tiva te d  blank values 
1 Animal : x 150 p e lle t  d i lu t io n :
L-TRY 5.67 X 10 Incubate a t 37°C fo r  30 mins a t pH 8.1










8 animals: X 150 p e lle t  d i lu t io n :  L-TRY concentra tion
5.67 X 10 (222,000dpm). Incubate a t 37°C fo r  30 mins a t pH 8.1.












Coeff. of variance 0.955%
Table 6
Animal variation
8 animais : x 150 p e lle t  d i lu t io n :  L-TRY
5.67 X 10 (222,000 dpm). Incubate 37°C fo r  30 mins pH 8.1












C oeff. o f variance (S.D ^ ^ 2.79%
(Mean )
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14amounts of DL- C TRY were used 0.025, 0.05, 0.1, 0.2 and
0.4 fici (i.e. the effective L-TRY amounts are half these 
values). As seen from Fig. 37 an increase in specific 
activity produced a proportional increase in d.p.m., 
which was linear over the range investigated. This 
ensured that there was no deleterious effect in altering 
the amount of radioactive substrate used in these 
experiments,
Expt. 6 A comparison of acid-inactivated and heat- 
inactivated blanks.
Table 4 shows the blank values were reduced by 32% when 
the enzyme preparation was destroyed by boiling rather 
than acid.
Expt. 7 Method and animal variation.
Tables 5 and 6 show the coefficient of variance for the 
method and animal variation to be respectively 0.955% 
and 2.79%. These figures were used to calculate the 
smallest variation (0.55 nmol/g/hr) in enzyme activity 
detectable with the method used.
Having established the appropriate conditions for estimating 
the activity of TRY hydroxylase, the enzyme's activity was 
measured at 6 clock hours. Groups of 8 rats housed for 
two weeks under the conditions described in Chapter 2 
were sacrificed at 4 hourly intervals. The braing were 
rapidly removed and assayed as described in Section 5.2.
Fig. 38 The 24-hour variation in TRY hydroxylase activity.
Conditions of incubation - pH8, 31^C, 30 min; 500 
p,mol Tris acetate buffer, 1.25 mmol sucrose, 1.5 ml 
of X 150 dilution of enzyme prep^, 5.67 x 10“^M L-TRY 
(25 nmol L-TRY + 6.7 nmol ^^C DL-TRY) final concis, 
n = 8 at each clock hour.
Velocity expressed as nmoles 5-HT produced/g wet 
weight/hour.





















The 24-hour variation of TRY hydroxylase activity
As seen from Fig. 38 no circadian rhythm in TRY hydroxylase 
activity was found to exist in the rat brain.
5.4 Discussion
Early methods used to determine the in vitro activity of 
TRY hydroxylase were based on the determination of radio­
active 5-HT, which was separated from a large excess of 
unreacted TRY by paper chromatography, paper electro­
phoresis or ion-exchange resins. Various methods have 
been developed in an attempt to overcome these lengthy 
separations such as direct determination of 5-HTP (Friedman 
et al., 1972), a tritium release assay (Lovenberg et al., 
1971), a carbon dioxide trapping method (Ichiyama et al., 
1970) and the formation of melatonin (Saavedra et al., 1973)
The method involving the direct determination of 5-HTP 
measured the enzyme activity in the synaptosomal fraction 
and also the soluble fraction after a 10-fold purification 
of the enzyme from rabbit hindbrain. The purification 
involved on extraction followed by adsorption and elution 
from calcium phosphate, then ammonium sulphate fraction­
ation. The enzyme samples could be stored under nitrogen 
at -80° in small aliquots after being quick dried.
Incubation was carried out at 25 mins at 37°C and the 
reaction stopped with 70% HCIO^. After centrifugation, the 
5-HTP was determined in the supernatant fluorimetrically 
(in concentrated HCl emission 538 nm excitation 295nm).
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Table 7
24 hour v a r ia t io n  in  tryptophan hydroxylase a c t iv i t y
14Clock Hour nmol COp produced/g/hr
12.00 8.58 + 0.24
16.00 8.21 + 0.16
20.00 7.42 + 0.28
24.00 8.45 + 0.31
04.00 7.64 + 0.22
08.00 7.17 + 0.31
12.00 8.84 + 0.18
X 150 p e lle t  d i lu t io n :
5.67 X 10“ ^ M L-TRY. Incubated a t 37°C fo r  30 mins 
a t pH 8.1. Each re s u lt  is  mean o f 8 animals.
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This method is based on the fact that, under defined 
conditions 5-HTP fluoresces whereas TRY does not 
(Udenfriend, 1962). This method was not found to be 
particularly sensitive when tested in our laboratories.
The method of Lovenberg et al., (1971) measures the activity 
of TRY hydroxylase using {5-^H} TRY as substrate. When 
hydroxylation occurs at the 5 position on the indole ring, 
the tritium shifts to the 4 position. Subsequent 
acidification of the reaction mixture causes the release 
of tritiated water. This assay requires the chemical 
synthesis and purification of {5-^H} TRY, which is time 
consuming (the purification involves two chromatographic 
separations on an amino acid analyser), and the resulting 
product is stable for only 3 to 4 weeks.
The method of Saavedra et al., (1973) is based on the
conversion of TRY to 5-HT and the conversion of the latter 
to {^H} melatonin by a two step reaction involving the 
N-acetylation of 5-HT to form N-acetyl 5-HT, followed by
the 0-methylation of N-acetyl 5-HT to form melatonin,
3 3utilizing { H } methyl-S-adenosyl-L-methionine ( { H } -SAM)
as the methyl donor. {^H} melatonin is isolated from the 
{^H} SAM by a simple organic extraction. Under the 
conditions of the assay {^H} melatonin is the only radio­
active product isolated in detectable amounts. The assay 
requires the preparation of partially purified N-acetyl- 
transferase, 5-HTP decarboxylase and hydroxyindole-0- 
methyltransferase. Although the method is a sensitive
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radio-enzymatic microtechnique for measuring 5-HT and its 
synthesising enzymes in discrete brain regions, it involves 
intricate multi-step reactions and is not a simple assay 
to establish.
The advantages of the carbon dioxide trapping method are
that no separation is required so a simple and rapid method
is available. It is also reliable as the sensitivity is
relatively high and there is no possibility of
contaminating ^^C02 with other radioactive materials. The
disadvantages are that it cannot be applied to crude
fractions from tissues such as liver where alternative
pathways are known to exist for the catabolism of TRY. Also,
it is apparent that in a reaction mixture containing
relatively high concentrations of TRY an appreciable amount
of CO2 evolved will be due to tryptamine formation instead
of 5-HT formation. Therefore substrate concentrations
above the Km should not be used for the assay. For these
reasons the last method described was chosen for this work.
As the assay was performed on rat brain and low substrate
concentrations were used (the concentration in the standard
-6assay was 5.67 x 10 M), the main disadvantages of the 
method did not apply. Further a synaptosomal preparation 
was used so the addition of cofactor, partially purified 
5-HTP decarboxylase, and reagents necessary to assay the 
soluble fraction as described previously were not required.
Certain unexpected problems were encountered, these being 
the relatively high blank values and the loss of linearity
14 1
in 5-HT production with time except at the dilution and 
substrate concentration used in the standard method. The 
high blank values varied only when the specific activity of 
the substrate varied. There was a 32% reduction in the 
blank value if inactivation of the enzyme was achieved by 
boiling rather than with acid. An explanation is that the 
acid itself is cleaving from the substrate causing a
non-enzymatic production. Under normal conditions an 
incubation cannot be terminated by placing the sealed 
bottle in boiling water, thus acid must be used.
The loss of linearity of 5-HT production with time could be 
explained by end-product inhibition, a lack of oxygen, 
deterioration of the enzyme preparation with time or 
cofactor availability. In vitro, end-product inhibition 
appears not to be a significant regulatory mechanism in 
the serotonergic system. It has been shown that 5-HT 
inhibits the enzyme only in high concentrations (greater
-  3
than 10 M) and then in a non-competitive way (Jequier 
et al. , 1969 ; Knapp and Mandell, 1973) even with the more 
effective cofactors. In vivo, however, Hamon et al.,(1973) 
have demonstrated that manoeuvres intended to increase 
(e.g. MAO inhibition) or decrease (e.g. reserpine induced 
depletion) intraneuronal 5-HT led to a decrease and increase 
in total 5-HT, respectively. 5-HT synthesis was reduced 
when intraneuronal levels of the amine reached 2.5 times 
normal levels following MAO inhibition (Macon et al., 1971) 
Carlsson et al., (1973b) observed a decrease in the rate of
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5-HTP accumulation induced by a decarboxylase inhibitor 
in mice injected with a MAO inhibitor. The decrease was 
not observed when inhibitors of the two enzymes were 
given simultaneously but only when the MAO inhibitor 
was given beforehand, leading to an increased 5-HT level. 
Also the two hallucinogenic agents LSD-25 and dimethyl- 
tryptamine caused a reduction of the 5-HTP accumulation. 
These agents are believed to activate postsynaptic 
receptors. Thus conflicting results regarding the role 
of end-product feedback inhibition exist. In vitro 
experiments suggest that 5-HT is not a probable regulatory 
molecule for modulating TRY hydroxylase activity because 
too great a concentration of 5-HT is required to do so, 
and the inhibition is non-competitive. The experiments 
in vivo however, suggest that treatments that increase 
extravesicular, intraneuronal 5-HT decrease 5-HT bio­
synthesis and that treatments that decrease the levels 
have an opposite effect.
As the circadian rhythm of brain TRY is out of phase 
with that for 5-HT and as evidence suggests TRY hydroxylase 
is the rate-limiting step in the formation of 5-HT, 
it seemed a logical step to assay the activity of the 
enzyme over 24 hours. If evidence of variation in the 
enzyme activity was apparent, it might indicate an 
important regulatory step in controlling 5-HT levels. As 
seen from the results, however, no variation in activity was 
observed. These results differ from those of Shibuya et al. , 
(1978) who found a clear 24-hour rhythm in TRY hydroxylase
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activity of the pineal body. In the latter, 5-HT 
shows a rhythm (Quay, 1963) with the opposite phase of 
the marked circadian rhythms of N-acetyltransferase 
(Klein et al., 1970), N-acetylserotonin (Klein et al.,
1970) and melatonin (Ralph et al., 1971) . A suggestion was 
made that pineal TRY hydroxylase in the rat may have a 
different value from that in the brain (Deguchi and 
Barchas, 1973) and these results would tend to substantiate 
these findings.
Having been unable to find any variation in enzyme activity 
connected with clock hour using an in vitro method, it was 
decided to continue investigation of factors controlling 
the 24-hour variation of 5-HT by using a behavioural model. 
By using in vitro methods the possibility of investigating 
short-term regulation via nerve stimulation (e.g. feedback 
control of synthesis via a neuronal loop as opposed to 
local end-production inhibition) is not feasible. It was 
thought that by using a behavioural model, which represented 
activation of central serotonergic receptors by enhancing 
the 'availability' of 5-HT at post-synaptic receptor sites, 
and to study this over 24 hours might provide more evidence 
as to how the activity of serotonergic neurons are 
regulated.
CHAPTER SIX
The 24-hour variation in 
TRY-induced hyperactivity in rats
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6.1 Introduction
When rats are treated with a combination of monoamine oxidase 
inhibitor (MAOI) and L-TRY, they develop a syndrome of 
hyperactivity, hyperpyrexia, reciprocal forepaw treading, 
head weaving and hind-limb abduction (Hess and Doepnfer,
1961; Grahame-Smith, 1971a). Grahame-Smith has elucidated 
the neurochemical mechanisms underlying this syndrome and 
used it to investigate agents of potential clinical value 
in the treatment of neurological and psychiatric disorders, 
in which disturbances of endogenous central 5-HT levels 
have been implicated.
Biochemical analysis showed an increasing accumulation of 
brain 5-HT with increasing L-TRY doses up to I2 0mg/kg 
L-TRY and a brain TRY concentration of approximately 70jj,g/g 
brain weight. Above this dose and concentration no further 
increase in brain 5-HT accumulation occurred (Grahame-Smith, 
1971a). Monoamine inhibition, L-TRY administration and 
intact TRY hydroxylase and 5-HTP decarboxylase activity 
were all shown to be essential prerequisites for the 
production of the behavioural syndrome (Grahame-Smith, 1971a) 
Indices of hyperactivity correlated with the amount of brain
5-HT accumulating in 1 hour after L-TRY loading but not with
, / ■' '
the absolute concentration of brain 5-HT, suggesting hyper- 
activity was dependant upon the rate of 5-HT synthesis. 
Reserpine and tetrabenezine, which both inhibit the uptake 
of and storage of 5-HT by intraneuronal granules (Pletscher 
et al., 1968; Carlsson, 1966), speeded the onset and rate of 
development of the hyperactive state without altering the
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the synthesis of brain 5-HT. These results led Grahame- 
Smith (1971a) to suggest that when MAO is inhibited and 
the rate of 5-HT synthesis is increased, granular storage 
of 5-HT and other rate-limiting mechanisms for 5-HT, 
inactivation are unable to prevent 5-HT 'spilling over' to 
produce hyperactivity. Evidence for this syndrome being 
mediated by serotonergic neurons was further substantiated 
by the use of the hallucinogenic drug, 5-Methoxy-N,N- 
dimethyltryptamine (5 Me0DMT), which is a 5-HT post­
synaptic receptor agonist (Ahlborg et al., 1968). This drug 
produced a syndrome of hyperactivity, which was qualitatively 
identical to that produced by an MAOI and L-TRY but had a 
more rapid onset and was of shorter duration (Grahame-Smith, 
1971b). The similarity of the syndromes suggested that 
5-HT and 5 MeODMT were acting at the same sites. PCPA did 
not inhibit the behavioural effects of 5 MeODMT unlike those 
produced by an MAOI and L-TRY and this was indirect (but 
not absolute) evidence against 5 MeODMT acting through the 
release of endogenous brain 5-HT.
This work led to the proposal that the syndrome represented 
a model for 5-HT receptor activity. However, this conclusion 
was questioned when certain observations were reported to 
implicate the possible involvement of DA in the expression 
of the syndrome.
It was found that an MAOI plus L-DOPA produced a similar 
though not identical excitatory behaviour (Jacobs, 1974;
Green and Grahame-Smith, 1974) . Because of the overt 
similarity in these 2 syndromes, Jacobs (1974) proposed
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that they might be dependant upon a common neurotransmitter.
He tested this theory by observing whether blockade of either 
5-HT or DA biosynthesis or their respective receptors was 
capable of blocking the production of the syndrome produced 
by precursors of the other transmitter. He found that 
pretreatment with a-methyl-p-tyrosine (a-MPT), a tyrosine 
hydroxylase inhibitor, failed to affect either the syndrome 
produced by an MAOI and L-TRY or that produced by an MAOI 
and L-DOPA, whereas PCPA blocked both. Similarly pimozide, 
a DA receptor antagonist had no effect on either syndrome 
while cinanserin and methysergide, 5-HT receptor antagonists 
abolished or markedly diminished both syndromes equally.
Jacobs (1974) concluded that the effect of L-DOPA was 
mediated by 5-HT rather than DA and suggested that as L-DOPA 
increased the efflux of 5-HT from brain slices (Ng et al.,1970) 
perhaps the large injections of L-DOPA were increasing the 
release of 5-HT which could be maintained in a functional 
state for a longer period of time because of MAO inhibition. 
However, Green and Grahame-Smith (197 4) found contrasting 
results in that a-MPT inhibited the hyperactivity due to an 
MAOI and L-TRY or 5 MeODMT. Brain 5-HT and TRY levels rose, 
while NA and DA levels were depleted by 75%. The administra­
tion of L-DOPA 1 hour after a-MPT almost restored the brain 
DA concentrations, did not restore brain NA levels but did 
cause a return of the hyperactivity. An explanation for 
these differences was proposed by Sloviter and co-workers 
(1978) who compared gross activity recordings with quantal 
observation signs. They found rats pretreated with a-MPT
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were lethargic and exhibited little spontaneous movement.
When these rats received 5MeODMT all signs of the syndrome 
became evident but the rats were left with fewer gross 
body movements than were observed with SMeODMT alone.
These conflicting results do not help us to decide whether 
the syndrome requires an intact DA system for its expression 
or whether the syndrome caused by an MAOI and L-DOPA is a 
result of stimulation of DA or 5-HT receptors. Sloviter 
et al., (1978) found that depletion of catecholamines by 
a-MPT or 5-HT by either PCPA or 5,7 dihydroxytryptamine did 
not prevent the syndrome caused by 5-MeODMT. Pretreatment 
with methysergide but not phenoxybenzamine or pimozide 
prevented the syndrome caused by 5MeODMT and by an MAOI and 
L-DOPA. Conversely, 5-HT depletion prevented the syndrome 
caused by an MAOI and L-DOPA and the behavioural response 
was restored in PCPA treated rats by 5-HTP. Intraventricular 
injection of 5-HT or DA caused the behavioural syndrome 
after MAO inhibition. PCPA pretreatment prevented the 
syndrome caused by DA but did not prevent that caused by 5-HT.
These results suggest that systemic L-DOPA or intraventricular 
DÀ produces the behavioural signs through 5-HT mechanisms: 
endogenous catecholaminergic mechanisms are not involved 
directly in either the cause or expression of the behavioural 
syndrome. This syndrome is of importance as it represents 
a behavioural index of central serotonergic activity and has 
been used as such to study the action of various drugs such 
as chlorpromazine (Grahame-Smith, 1971b), diphenylhydrantion
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and chlorimipramine (Green and Grahame-Smith, 1975) and 
lithium (Grahame-Smith, 1974) which have been used in the 
treatment of psychiatric disorders in an attempt to 
elucidate their action on serotonergic neurons and to gain 
greater knowledge of factors controlling the functional 
activity of brain 5-HT. For these reasons, this syndrome 
provided an appropriate model with which to study processes 
regulating the 24-hour variation in 5-HT, particularly as 
gross hyperactivity could be measured by activity meters 
over 24 hours without disturbing the animal's rhythm.
Fig. 39 The effect of tranylcypramine (20mg/kg) on the 24- 
hour gross activity thythm of rats.































90-1lOg rats were housed in groups of 3 and maintained on 
the 12 hour light: 12 hour dark cycle previously described 
(Chapter 2) for 10 days. At the appropriate time of day, 
an experimental and control group were removed from their 
controlled environment and unless otherwise stated below 
were injected with pargyline,' followed 30 mins later with 
either L-TRY (experimental) or 0.9% saline (control). All 
injections were by the intraperitoneal route and doses 
varied according to the experiment. The 'Varimex' activity 
meters were placed in the boxes while the first set,of 
injections were performed to allow time for equilibration. 
They were linked to a device which recorded the activity 
monitored by alternate meters every 5 secs. These values 
were accumulated and printed out every 10 mins. Cages and 
bedding were weighed as differences affected the sensitivity 
of the meters. Injections performed in the dark period 
were carried out using a red light as described in Chapter 2. 
It should be emphasised that because of the nature of the 
experiments, it was not possible to observe the animals, nor 
therefore, to analyse the type of behaviour exhibited: only 
total activity scores are shown.
Expt. 1 The effect of increasing doses of L-TRY on the 
hyperactivity produced by an MAOI plus L-TRY over 24 hours. 
Groups of rats pretreated 30 mins earlier with 20mg/kg 
tranylcypromine were injected at 16.00 hr (10th hour of 
light) with either 20, 40 or 60 mg/kg L-TRY or with an equal
Fig. 40 The effect of pargyline (50mg/kg) on the 24-^hour 
gross activity rhythm of rats.












Fig. 41 The effect on gross activity of pargyline (50mg/kg)
and L-TRY (50mg/kg) administered at 4 different clock 
hours.
L-TRY (I.P.) a) 10.00 b) 16.00 c) 22.00 d) 04.00 
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volume of 0.9% saline. The activity of each group was then 
monitored for 24 hours.
Expt. 2. A comparison of the effect of paraglyne and !
trancylcypromine on the activity of rats measured over 24 
hours.
Rats were injected at 04.00 hr (10th hour of dark) with either 
pargyline (50 mg/kg) or tranylcypromine (20 mg/kg) and their 
activity compared to control groups injected with 0.9% saline.
Expt. 3. The effect of L-TRY plus pargyline injected at 6 
hourly intervals (i.e. 22.00, 04.00, 10.00 and 16.00 hours) 
on activity.
Groups of rats were injected with 50 mg/kg pargyline followed 
30 mins later with 50 mg/kg L-TRY or 0.9% saline at the 
clock hours stated. In each case gross activity was 
measured for a 6 hour period timed from the L-TRY injection. 
This was repeated at 16.00 and 04.00 hr using 75 mg/kg 
pargyline and 50 mg/kg L-TRY.
Expt. 4. The effect of 5 MeODMT injected at 6 hourly 
intervals on activity (5 MeODMT-hyperactivity).
The above experiment was repeated using 75 mg/kg pargyline 
and 2.5 and 10 mg/kg 5MeODMT or saline instead of L-TRY.
The larger dose (i.e. 10 mg/kg) was only injected at 16.00 
and 04.00 hr.
Fig. 42 The effect of pargyline (75 mg/kg) and L-TRY 
(50 mg/kg) administered at 16.00 hours.




























Expt. 5. The effect of chlorimiprainine on the hyperactivity 
induced by L-TRY plus pargyline (TRY-hyperactivity), 
injected at 6 hourly intervals.
Groups of rats were injected with 12.5 mg/kg chlorimiprainine 
followed 45 mins later by 75 mg/kg pargyline. 50 mg/kg 
L-TRY or saline was injected 30 mins after the pargyline 
dose at 22.00, 04.00, 10.00 and 16.00 hours. The dose of 
chlorimipramine was then increased to 25 mg/kg and the 
experiment repeated at 16.00 and 04.00 hours.
Expt. 6. The effect of nomifensine on TRY-hyperactivity. 
Groups of rats were injected with 10 or 20 mg/kg of 
nomifensine followed 45 mins later by 75 mg/kg pargyline.
50 mg/kg L-TRY or saline was injected 30 mins after the 
pargyline dose at 16.00 and 04.00 hr.
Fig. 43 The effect of pargyline (75 mg/kg) and L-TRY 
(75mg/kg) administered at 04.00 hours. 



























6.3 Results and Discussion
In experiment 1 varying doses of L-TRY were used in
combination with tranylcypromine to produce the hyperactivity
syndrome. These doses were quoted as suitable by Grahame-
Smith (19 71a); in my experiments, although the doses were
effective at producing hyperactivity, they were also lethal.
At 60 mg/kg L-TRY, all the experimental rats died, at 40 mg/kg, 
66% of the experimental rats died while at 20 mg/kg L-TRY,
33% died. Deaths were not immediate but occurred at least
4 hours after injection presumably due to the effect of 
excessive hyperpyrexia. It was also noted that the rhythms 
of the control rats were disrupted. This latter observation 
led to a comparison of the action of pargyline (50 mg/kg) 
and tranylcypromine (20 mg/kg) on the normal activity of rats 
measured over 24 hours. Fig. 39 shows that tranylcypromine 
produced a certain degree of hyperactivity and disrupted
the 24-hour rhythm of the rats. Normally, rats sleep during 
the light period and very little activity is recorded. The 
effects of tranylcypromine côuld be explained by its 
amphetamine-like effect causing excessive stimulation. For 
this reason pargyline was subsequently used as the monoamine 
oxidase inhibitor (Fig. 40).
Doses of pargyline and L-TRY were determined, which produced 
sub-maximal hyperactivity and which were not lethal. As 
the hyperactivity syndrome invariably lasted no longer than
5 hours, it was decided to measure activity over 6 hour 
periods timed from the L-TRY injection rather than over 24 
hours. Fig. 40 shows that the control animals' activity
Fig. 44 The effect on gross activity of pargyline (75 mg/kg) 
and 5 MeODMT (2.5 mg/kg) administered at 4 different 
clock hours.
5 MeODMT (I.P.) a) 10.00 b) 16.00 c) 22.00 d) 04.00 
Allpargyline injections (I.P.) 30 min prior to 5 MeODMT 
dosage.
------- exp (pargyline/5 MeODMT)
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Fig. 45 The effect of pargyline (75 mg/kg) and 5 MeODMT 
(10 mg/kg) administered at 04.00 hour.
Pargyline injected (I.P.) 30 min prior to 5 MeODMT 
dosage.
------ exp.(pargyline/SMeODMT)

























followed a normal cycle with greatest activity occurring 
during the dark phase which coincided with when the rats ate. 
Pretreatment with L-TRY plus pargyline did not affect this 
natural rhythm markedly except when the L-TRY was injected 
at 16.00 hr (Fig. 41). There was a significant increase in 
hyperactivity at this time which lasted well into the dark 
period. This effect was repeated when 75 mg/kg pargyline 
and 50 mg/kg L-TRY were injected at 16.00 and 04.00 hr 
(Figs. 42 and 43). Significant hyperactivity was seen at 
16.00 hr in contrast to that at 04.00 hr.
The extent of the TRY-hyperactivity induced in this way 
was compared to that produced by injecting pargyline (75 mg/ 
kg) followed 30 min later by 5 MeODMT (2.5 mg/kg) at the same 
4 clock hours. Fig. 44 shows the onset of hyperactivity was 
rapid and the duration of action was far shorter 
(approximately 2 hours) than that observed for the TRY- 
hyperactivity. The level of hyperactivity reached at each 
clock hour was markedly similar, only the rhythm of the 
control animals varying. It could be argued that maximal 
hyperactivity was reached or that a change in behavioural 
response occurred i.e. perhaps the pattern of the syndrome 
could change at high doses causing greater stereotyped 
behaviour which would not necessarily be reflected in an 
increase in total activity recorded. However, as Figs. 45 
and 4 6 show, when the dose of 5MeODMT was increased to 10 
mg/kg, a subsequent rise in hyperactivity was seen.
Fig. 46 The effect of pargyline (75 mg/kg) and 5 MeODMT 
(10 mg/kg) administered at 16.00 hour.
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Fig. 47 The effect on gross activity of nomifensine (lOmg/kg), 
pargyline (75mg/kg) and L-TRY (50mg/kg) administered 
at different clock hours.
L-TRY (I.P.) a) 16.00 b) 04.00
Nomifensine and pargyline injected (I.P.) 75 min and 
30 min prior to L-TRY, respectively.
-exp. (nomifensine/pargyline/L-TRY) 
•control (nomifensine/pargyline/saline).




























0 8 * 0 0 10*000 6 *0 00 4 -0 0
Fig. 47 clock hours
1 6 3
These results demonstrate a difference in response to TRY 
and 5MeODMT. As stated previously, 5 MeODMT is thought to 
be a post-synaptic receptor agonist of serotonergic neurones 
(Ahlborg et al., 1968). Therefore, these results again point 
to the conclusion that variation in response to TRY is due 
to' regulation by pre-synaptic mechanisms rather than changes 
in post-synaptic receptor sensitivity. Presynaptic 
regulation could involve synthesis, compartmentation and 
intraneuronal metabolism or re-uptake. Synthesis regulation 
has already been considered (Chapters 4 & 5), and previous 
work in our laboratories had indicated no 24-hour variation 
in monoamine oxidase activity. It was decided therefore to 
use this behavioural model to investigate the effects of 
blocking 5-HT re-uptake of serotonergic neurons using 
chlorimipramine (Carlsson et al., 1969a, 1969b), on the 
variation of TRY-hyperactivity. This also gave the 
opportunity to attempt to assess the role of dopamine in 
this syndrome by using a newly developed antidepressant drug, 
nomifensine, which selectively blocks catecholamine (and 
especially dopamine) re-uptake (Hoffman 1973; Hunt et al., 
1974). As Figs. 47 and 48 show, nomifensine (10 and 20 mg/kg) 
failed to potentiate the TRY-hyperactivity syndrome when 
measured at 16.00 and 04.00 hr. This is in contrast to the 
interesting effect seen when chlorimipramine was given 
together with L-TRY and pargyline. Fig.49 shows that the TRY- 
hyperactivity at 16.00 hr was unaltered by chlorimipramine 
pretreatment whereas the TRY-hyperactivity at the other clock 
hours increased greatly. The 24-hour variation, seen 
previously when only L-TRY and pargyline were given, was
Fig. 4 8 The effect on gross activity of nomifensine (20mg/kg) 
pargyline (75mg/kg) and L-TRY (50mg/kg) administered 
at 2 different clock hours.
Experimental detail - refer to Fig. 47.
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Fig. 49 The effect on gross activity of chlorimipramine
(12.5mg/kg), pargyline (75mg/kg), L-TRY (50mg/kg) 
administered at 4 different clock hours.
L-TRY (I.P.) a) 10.00 b) 16.00 c) 22.00 d) 04.00 
Chlorimipramine and pargyline injected (I.P.) 75 min 
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abolished when the rats were pretreated with chlorimipramine 
and it could again be argued that in each case a maximal 
effect was being observed. However, increasing the dose of 
chlorimipramine to 25 mg/kg increased hyperactivity still 
further at the 2 clock hours measured (Figs. 50 and 51).
Both L-TRY (in the presence of an MAOI) and 5 MeODMT produced 
a behavioural syndrome of hyperactivity which were distinguish­
able only by the onset and duration of action. The hyper­
activity produced by 5 MeODMT was consistently similar in 
magnitude and duration at each of the four clock hours 
measured. As 5 MeODMT is thought to be a post-synaptic 
receptor agonist, these results indicated that no variation 
in post-synaptic receptor sensitivity occurred. However, the 
hyperactivity produced by L-TRY and an MAOI showed a marked 
variation in that hyperactivity produced at 16.00 hr (lOth 
hour of light) was far more marked than at any of the other 
clock hours at whichever doses of drug were used. This 
again led to the conclusion that some pre-synaptic event(s) 
was responsible for controlling this variation. It was 
found that the circadian effect of the TRY-hyperactivity was 
abolished by the re-uptake blocker, chlorimipramine when 
this was injected prior to pargyline and L-TRY. The hyper­
activity was then evident at each clock hour and reached the 
same level in each instance although this level was not 
maximal, as increasing the dose of chlorimipramine 
increased the hyperactivity still further.
Two explanations arise to explain the variation in TRY- 
hyperactivity seen at different clock hours. The greatest
Fig. 50 The effect on gross activity of chlorimipramine
(25mg/kg), pargyline (75mg/kg) and L-TRY (5i3mg/kg) 
administered at 10.00 hour.
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Fig. 51 The effect on gross activity of chlorimipramine
(25mg/kg), pargyline (75mg/kg) and L-TRY (50mg/kg) 
administered at 16.00 hour.
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hyperactivity (seen at 16.00 hr) is either due to a 
release of greater quantities of 5-HT or to a decreased rate 
of 5-HT re-uptake. The latter could occur if the re-uptake 
rate was reduced. If re-uptake rate did exhibit variation 
with clock hour then the action of a re-uptake blocker 
might be to abolish the effects produced by the variation 
i.e. the difference in hyperactivity at different clock 
hours. As stated previously this is in fact the effect 
chlorimipramine produced; it abolished the variation in 
TRY-hyperactivity such that the hyperactivity at the other 
clock hours was increased to the level obtained at 16.00 
hours.
These results therefore suggest that the re-uptake of 5-HT
»
into serotonergic neurons may have a regulatory function.
This work provides a starting point from which to investigate 
this phenomenon more closely, particularly by biochemical 
methods. Wirtz-Justice and Hackman (19 73) have shown a 
circadian variation for the uptake of 5-HT in the hippo­
campus of the rat brain but were unable to find such a rhythm 
in other brain regions. The possibility that more 5-HT is 
available for release at any particular clock hour should 
also be investigated further. However, this will be 





A 24-hour variation in 5-HT levels in the rat brain as 
discussed in Chapter One has consistently been shown in the 
rat brain (Dixit and Buckley, 1967; Scheving et al., 1968; 
Schwartz and Aghajanian, 1969; Okada, 1971; Asano, i971; 
Davies and Redfern, 1970) . The peak value is reached in 
the light period when the animals are least active while the 
lowest levels coincide with the animals' peak activity. The 
reproducibility of this rhythm leads one to assume that it is 
under strict control. There is also a 180° phase difference 
between the 24-hour rhythms exhibited in brain 5-HT 
concentrations and brain TRY concentrations, the peak values 
of the latter occurring in the dark period when the maximal 
food intake of the rats occurs (Le Magnen et al., 1973) .
One explanation for the low 5-HT concentration in the dark 
period is that the turnover of 5-HT is greater. If this 
were the case, it could be argued that 5-HlAA levels should 
be raised during the dark phase. Previous findings in our 
laboratories showed the reverse i.e. the 24-hour variation 
in 5-HlAA levels closely followed that observed for 5-HT.
In addition, the activity of MAO did not vary throughout 
24 hours. This strongly suggested that endogenous TRY 
concentrations do not control the 24-hour rhythm of 5-HT 
in the rat brain.
From these results it appeared that some pre-synaptic 
event(s) was controlling the conversion of TRY to 5-HT in 
the brain to account for the phase difference in their
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respective rhythms. When considering neurotransmitter 
regulation, it is generally assumed that a neuron 
manufactures only the amount of amine which it requires 
and that every molecule of metabolite (in this case 5-HlAA) 
produced equals one molecule of amine released. On this 
principle the rate of 5-HT synthesis must be precisely 
'tuned* to function. Based on this assumption turnover 
studies in vivo measuring the utilization rate of transmitter 
molecules have been used as a reflection of the rate of 
synaptic transactions. The most likely sites for biosynthetic 
'tuning' are via precursor availability in the brain and 
within the neuron itself and by regulation of synthetic 
enzyme activity.
Precursor availability
As stated previously a 180° phase difference between the 24- 
hour rhythms in brain TRY and 5-HY levels exists which is 
indicative of factors other than total brain TRY levels 
controlling 5-HT brain concentrations. However, as discussed 
in Chapter 3, TRY exhibits the unusual property of binding 
to serum albumin (McMenamy et al., 1957) which led to the 
suggestion that it is the plasma free TRY which is the 
functionally important fraction in determining the availability 
of circulating TRY to the brain and other tissues (Knott and 
Curzon, 1972) . Perhaps an analogous situation occurs in the 
brain such that estimation of total brain TRY levels gives 
misleading results for precursor availability and it is 
levels of 'free' TRY in the brain which determine the latter.
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For these reasons it was decided to measure the concentration 
of 'free' brain TRY over 24 hours as well as total brain TRY 
levels. The results obtained (Fig. 20) show that there is a 
24-hour variation in 'free' TRY but that the peak values 
occur in the dark period and the rhythm thus closely follows 
that for total brain TRY, suggesting neither 'free' nor total 
brain TRY are directly responsible for the fluctuations 
consistently measured in 5-HT levels.
In retrospect, it does seem unlikely that a neurotransmitter 
such as 5-HT, which is possibly involved in such diverse 
functions as regulation of various types of behaviour, body 
temperature and sleep, sexual activity, neuroendocrine 
function would be subject to functional control by dietary 
intake as discussed in Chapter 3. It is interesting however 
that all 3 major constituents of the diet i.e. carbohydrate, 
protein and fat can affect brain 5-HT and possibly suggests 
a focal role for 5-HT neurons, in allowing the brain to 
sense peripheral metabolism. It would make some physiological 
sense if a family of neurons whose function depends on the 
scarcest amino acid should 'inform' the rest of the brain 
about the state of the body's metabolism.
TRY uptake
TRY uptake by synaptosomes from the external medium is 
temperature dependent, inhibited by metabolic inhibitors but 
not very sensitive to changes in the external concentration 
of Na^ or k "*". There appear to be two systems operating.
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a low and a high affinity uptake system. Synaptosomes can 
therefore concentrate TRY. However, the other neutral 
amino acids inhibit TRY uptake (Grahame-Smith and Parfitt, 
1970; Parfitt and Grahame-Smith, 1974). Synaptosomes also 
show exchange diffusion which is a mechanism whereby a 
molecule being transported in one direction is linked to 
efflux and vice versa. It was noted (Grahame-Smith and 
Parfitt, 1970) that a range of amino acids could exchange 
with TRY and that the exchange was stereospecific. Clearly 
therefore, there is no system specifically transporting TRY 
alone across the neural membrane. The process being shared 
by several amino acids. Furthermore, TRY uptake does not 
appear specific to serotonergic neurons. A high affinity 
transport system was demonstrated in synaptosomal 
preparations free of serotonergic terminals (Kuhar et al., 
1972) and in various cultured cells such as glial cells, 
fibroblasts and neuroblastoma clones (Bauman et al., 1974). 
Knapp and Mandell (1972, 1973), investigating the high 
affinity uptake system, found a disparity between the Vmax 
of the uptake system and the conversion of TRY, which was 
found to be at least two orders of magnitude lower (Knapp 
and Mandell, 1972). Moreover, Kuhar et al., (1972) showed 
that whereas electrolytic lesion in the median raphç 
reduced forebrain TRY hydroxylase, it did not signi^acantly 
reduce the relative velocity of the high affinity TRY uptake 
system in the forebrain. Both these findings suggest that 
the high affinity uptake system may not be specific to 
serotonergic neurons nor indeed, a controlling mechanism.
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If a specific uptake mechanism existed for the transport 
of TRY into serotonergic neurons then the synthesis of 
5-HT could be controlled by regulating TRY uptake and thus 
determining a crucial intracellular concentration of TRY in 
the vicinity of TRY hydroxylase. However the evidence 
presented here suggests no such specific mechanism exists.
The fact that the TRY transport appears non-specific with 
respect to serotonergic neurons and selective uptake makes 
it unlikely that the control of 5-HT synthesis is finely 
regulated via modulation of TRY uptake into nerve endings.
For these reasons, it was decided not to investigate TRY 
uptake over 24 hours but to concentrate on studying the 
synthetic enzymes responsible for the conversion of TRY to 
5-HT namely TRY hydroxylase and 5-HTP decaboxylase.
The activity of 5-HTP decarboxylase
As stated in Chapter 4 the reason for studying the activity 
of this enzyme was that preliminary findings in our 
laboratories had indicated a circadian variation in the 
activity of a crude enzymatic extract (Hillier and Redfern, 
1976). However using a different though equally sensitive 
method I was unable to repeat this finding. No statistically 
significant circadian variation was apparent using Fourier's 
analysis although a significant difference existed between 
5-HTP decarboxylase activity measured at 17.00 and 05.00 
hours. Although these experiments did not substantiate the 
preliminary findings it is interesting to note that the 
rhythm in enzyme activity shown previously was abolished 
upon purification of the preparation (Hillier and Redfern,1976)
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It was shown that the variation was not due to the 
availability of P5P or to the enzyme being saturated with 
substrate (Hillier and Redfern,1976). This indicated that 
the variation observed was not due to an actual change in 
enzyme activity but to some substance present in the crude 
extract which was capable of influencing activity. The 
suggestion was made that competition for the enzyme by 
different substrates may play a role since a large number of 
amino acids can be taken up by 5-HT containing neurons. 
Particular interest was focussed on competition between DOPA 
and 5-HT. It has been reported for instance that L-DOPA 
decreases the deamination of 5-HT (Karobath et al., 1972) 
and that DOPA and 5-HTP compete for the same enzymatic site 
(Yuwiler et al. , 1960) . It is also interesting that the 
24-hour variation in DA and NA levels are 18 0° out of phase with
that exhibited for 5-HT (Reis and Wurtman,1968; Hillier et al.,1 
Perhaps if levels of the precursors DOPA and 5-HTP vary at
different clock hours then the decarboxylation of the one
attaining the higher concentration may competitively inhibit
the conversion of the other.
I believe, however, it is unlikely that 5-HTP decarboxylase 
could exert a controlling influence on 5-HT synthesis when 
the properties of the enzyme TRY hydroxylase are considered.
TRY hydroxylase is responsible for the first step in the 
synthesis of 5-HT i.e. the conversion of TRY to 5-HTP. The 
maximum velocity of this enzyme is far lower than that of 
5-HTP decarboxylase (Ichiyama et al., 19 68) and thus
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endogenous levels of 5-HTP in the rat brain are negligible 
(Lindquist et al., 1975) suggesting that TRY hydroxylase is 
the rate-limiting step in the pathway. It would seem 
feasible that a far more effective regulation of 5-HT 
synthesis could be exerted by the activity of TRY hydroxylase 
especially as evidence discussed in Chapters 3 and 5 indicate 
it is not saturated with its substrate under normal 
physiological conditions. For these reasons, the activity of 
this enzyme was estimated over 24 hours.
The activity of TRY hydroxylase
14Using an in vitro method involving CO^ trapping and a 
synaptosomal preparation, no 24-hour variation in activity 
was observed. This suggested that activity of the enzyme 
was not affected by the availability of the endogenous co­
factor or by end product inhibition as regulation by either 
of these factors would have been evident using an in vitro 
method. Had a rhythm been in evidence the relative 
contribution of these factors towards regulation of the 
enzyme's activity would have required further investigation. 
The problem associated with using in vitro methods to assay 
enzyme activity is that the effect of nerve stimulation and 
hence feedback control via neuronal loops is eliminated.
That depolarisation stimulates 5-HT synthesis was originally 
demonstrated by Anden et al., (19 64), who observed an increase 
in the formation of the transmitter in the isolated spinal 
cords of mice, subjected to electrical field stimulation.
5-HT synthesis is also accelerated in vivo by electrical 
stimulation of the raphe nuclei (Shield and Eccleston,
1972; Eccleston et al., 1970). Conversely, the interruption 
of nerve impulse flow in serotonergic neurons induced by 
transection of the spinal cord in the rat is rapidly 
followed by a decrease in the rate of TRY hydroxylase 
(Carlsson et al., 1973). Also the effects on 5-HT synthesis 
induced by nerve stimulation or by interruption of firing 
are still observed in rats injected with large quantities 
of TRY. This indicated that in vivo the activity of TRY 
hydroxylase could be dependent on nerve impulse flow possibly 
via changes in the affinity of the enzyme for the endogenous 
cofactor since it was unrelated to the concentration of TRY 
(Eccleston et al., 1970). From the evidence discussed in 
Chapter 3 concerning the concept that alterations in plasma 
'free' and brain TRY concentrations control 5-HT biosynthesis 
it would appear that these changes are by no means the only 
way of functional regulation.
The basic problems inherent in studying enzyme kinetics 
centrally will not be solved until technical advances allow 
the estimation of the concentration of neurotransmitter 
precursors within neurons and also within specific 
populations of neurons (e.g. the relatively few that actually 
convert TRY to the related monoamine) and ultimately within 
specific regions of those neurons (e.g. the perikarya, which 
uses TRY for protein synthesis and the nerve terminals which 
are probably the major locus of neurotransmitter synthesis).
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These concentrations are probably of major significance 
in determining the saturation and thus the in vivo 
activities of enzymes that control the utilization of 
substrates. The true flux of amino acid substrates into 
the brain, into neurons as a group, into specific neurons 
and finally into subcellular regions is important as this 
governs the concentrations within the neurons. Also the 
extent to which amino acid substrates stored intraneuronally 
as protein could be used for the synthesis of neurotransmitte: 
may be important. No variation in activity was found for 
TRY hydroxylase and 5-HTP decarboxylase using in vitro 
methods and the rhythm for 'free' TRY in the brain followed 
closely that for total TRY. So far, no explanation for the 
phase difference between the circadian rhythm in TRY brain 
levels and that of 5-HT levels was apparent. It was then 
decided to use a behavioural model thought to reflect the 
action of central serotonergic neurons and to manipulate 
factors which alter 5-HT synthesis pharmacologically, in 
the hope that this in vivo study might provide more positive 
results concerning functional regulation.
The behavioural study
To summarise the results from the behavioural work, it was 
found that TRY-induced hyperactivity showed a circadian 
effect, the greatest hyperactivity being consistently seen 
at the 10th hour of light and lasting well into th,e dark 
period. In contrast 5 MeODMT-induced hyperactivity showed 
no variation at any clock hour measured. As 5 MeODMT is 
regarded as a 5-HT receptor agonist (Ahlborg et al., 19 68)
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it was suggested that no fluctuation in post-synaptic 
receptor sensitivity occurred, again indicating that pre- 
synaptic mechanisms were governing the conversion of TRY 
to 5-HT. Having found no evidence of regulation via the 
synthetic enzymes using biochemical in vitro studies, 
the other pre-synaptic factors which could be involved in 
regulation are compartmentation, intraneuronal metabolism 
and re-uptake. For the reasons discussed in Chapter 6 
the effect of blocking the re-uptake of 5-HT into serotonergic 
neurons on the variation in TRY-hyperactivity was studied. 
Chlorimipramine when injected prior to L-TRY and an MAOI 
abolished the variation in hyperactivity, the latter then 
reaching the same level at each clock hour. As discussed 
in Chapter 6 this indicated a variation in re-uptake rate 
rather than a variation in 5-HT release. Conclusive 
evidence of this however would require further work 
particularly biochemical studies. Tricyclic drugs known to 
block 5-HT uptake (e.g. imipramine and chlorimipramine) 
inhibit raphe unit firing (Sheard et al., 1972). It has 
been proposed that these drugs may cause a reduction in 5-HT 
turnover by means of feedback inhibition of raphe neurons 
(Corrodi and Fuxe, 19 69) . Perhaps some feedback mechanism 
may exist to control the rate of re-uptake over 24 hours.
When considering the regulation of 5-HT biosynthesis, two 
concepts can be presented as follows:-
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1. Any estimate of 5-HT synthesis and turnover relies on 
the assumption that these processes reflect the activity 
of brain serotonergic neurons. The implication of this
is that a neuron manufactures only the amount of 5-HT which 
it uses and that every molecule of 5-HIAA produced 
represents one molecule of 5-HT released.On this principle 
the rate of 5-HT synthesis must be precisely 'tuned' to 
function.
2. An alternative possibility is that 5-HT is normally 
synthesised in excess of functional needs and that the 
amount of 5-HT actually released is only a proportion of 
that synthesised. Mechanisms are probably available for the 
removal of the excess 5-HT synthesised. Storage vesicles 
are probably not saturated and intraneuronal MAO is 
available to 'inactivitate' any free 5-HT which reaches it.
If the rate of synthesis is in excess of the rate of 
release and if intraneuronal binding and metabolism operate 
in a controlled manner. These latter processes might be 
more important than synthesis in regulating the size of a 
releasable pool.
In attempting to explain the 180° phase difference between 
the 24-hour variation in brain TYR and 5-HT levels the 
results presented in this thesis have led, in fact, to the 
conclusion that the availability of brain TRY ('free'and 
total), TRY hydroxylase and 5-HTP decarboxylase activity need 
not be the fine controls by which the amounts of 5-HT are 
available for functional activity. The behavioural studies
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indicate again however that the variation in activity is 
controlled by a pre-synaptic rather than a post-synaptic 
event. These conclusions indicate (although untested) 
that maybe it is intraneuronal binding and metabolism 
together with re-uptake that are important, and therefore 
support the second theory proposed. Perhaps the most 
relevant finding, supporting this theory is that when TRY 
is given alone to rats, no gross behavioural change occurs 
yet when TRY is given to rats pretreated with an MAOI, a 
hyperactivity syndrome is seen. These two situations 
differ only in regard to the inhibition of MAO. With TRY 
alone the 5-HT synthesised does not exert functional 
activity i.e. behavioural change because of the binding 
capacity of intraneuronal vesicles and the activity of MAO. 
With TRY plus a MAOI, 5-HT is being synthesised at an 
equivalent rate, presumably saturating storage sites and 
'spilling over' into functional activity (Grahame-Smith 1971b) 
Further evidence to support this theory is that lithium can 
produce a 70% increase in 5-HT turnover but no overt 
behavioural changes (Grahame-Smith and Green, 19 74). The 
observation of animal behaviour is a relatively crude index 
of drug action and this makes extrapolation from animal 
neuropharmacology to changes in the human mind, such as 
mood, extremely difficult. Thus, a failure to observe a 
behavioural change in animals is no proof that a change in 
mental function would not have occurred in man. Nevertheless 
there is some clinical evidence to suggest that large plasma 
TRY changes can occur acutely with little effect on mood.
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Greenwood et al., (19 74) infused intravenous TRY up to a
dose of 100 mg/kg producing a forty-fold increase in free 
TRY and an eight fold increase in the bound form. Few 
differences were observed in objective psychological tests 
although there were minor EEG changes and some changes in 
mood self-rating scales. Green et al., (1978) gave L-TRY
(50 mg/kg) orally as part of a metabolic study and 
produced a seven fold increase in total TRY levels in 
plasma. The 24 subjects reported no subjective changes 
in mood or ability to perform normal tasks.
However, there is evidence that giving TRY alone (Broadhurst, 
1970) or with an MAOI (Coppen et al., 1963; Pare, 1963; 
Glassman and Platman, 1969) is effective in the treatment of 
depression. It has to be considered that the anti­
depressant effect of TRY could be due to the formation in 
the brain of compounds other than 5-HT. For instance 
tryptamine (Saavedra and Axelrod, 19 73; Marsden and Curson,
19 74) and 5 methoxytryptamine (Green et al., 1973; Green 
et al., 1975), both of which have been found in the brain 
and produce behavioural effects.
If the control of the amount of 5-HT available for activity 
is exerted upon vesicular binding and oxidative deamination 
one specific problem arises when one attempts to distinguish 
between functionally active and functionally inactive 5-HT. 
5-HT released into the synaptic cleft, re-uptaken and 
intraneuronally metabolised has exerted a post-synaptic
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effect i.e. it has been functionally active. If 5-HT is 
produced in excess of needs and the excess is controlled 
by storage and intraneuronal metabolism, then the latter 
is functionally inactive. This places doubts on turnover 
studies reliant on 5-HIAA estimations as reflections of 
the functional state of 5-HT dependent neurons as the 5-HIAA 
could be derived from 2 pools,one from released 5-HT and 
the other from non-released 5-HT oxidatively deaminated 
within the neuron.
^  functionally active
synthesis
-------------- y 5-HT metabolism 5-HIAA
functionally inactive
This also highlights the hazards of interpreting changes 
in CSF 5-HIAA levels associated with affective disorders, 
in terms of the functional activity of 5-HT and its primary 
aetiological involvement in psychiatric disorders. Perhaps 
these ideas however can explain why 5-HT levels appear so 
susceptible in particular instances to plasma TRY 
fluctuations. If 5-HT is synthesised in excess then as 
long as MAO is intact, fluctuations in 5-HT levels will in 
no way affect serotonergic function.
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The behavioural studies indicate a diurnal variation in 
re-uptake. It is possible that this could affect the 
magnitude of the response to 5-HT at the post-synaptic 
receptors and would therefore be affecting functional 5-HT 
once it is released. However, this provides no insight 
into factors controlling functional 5-HT intraneuronally 
i.e. intraneuronal binding and MAO activity. The effect of 
the latter systems in regulating the 24-hour variation in 
5-HT levels will be far more difficult to establish. One 
difficulty arises from the inability to inhibit intra- and 
extraneuronal MAO activity differentially. Another problem 
is that the control of 5-HT could depend upon the relative 
activities of the different forms of MAO. MAO has been 
shown to exist in 2 forms, 'Type A ' and 'Type B ' (Youdim and 
Sandler, 1967) and the latter is ineffective in metabolising 
5-HT. If these forms do indeed metabolise monoamines 
differently in vivo, changes in activity could occur in one 
form, thus controlling a particular amine concentration 
without altering others. These changes would be masked if 
total MAO activity alone were measured. For these reasons, 
an interesting study for further work would be the effect 
of specific 'type A ' and 'type B ' MAO inhibitors in 
combination with L-TRY to produce hyperactivity, Uping 
respectively, clorgyline (Johnston, 1968) and deprenil 
(Sandler and Youdim, 1974; Houslay and Tipton, 1974). Also 
the effect of disrupting vesicular binding on the TRY- 
hyperactivity syndrome over 24 hours and a comparison of 
the action of other 5-HT re-uptake inhibitors e.g. Lilly
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